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INTRODUCTION 
1.1. Definition 
 
Endometriosis can be defined as the growth of endometrial tissues composed 
of both glandular and stromal elements at an extrauterine site1, which can 
cause dysmenorrhea, dyspareunia, non-cyclical pain and subfertility, whereas 
endometriomas are cysts of endometriosis within the ovary2. 
 
1.2.  History of endometriosis 
 
Knapp3 summarized the earlier descriptions of endometriosis in the 17th-18th 
centuries. The oldest publication about endometriosis can be traced 
approximately 300 years back to Shroen4 in his book called Disputatio 
Inauguralis Medica de Ulceribus Ulceri in 16904. In the 18th century, 
Roederer5 (in his book de ulceribus utero molestis observationibus), 
Broughton6, Tailford7, Duff8, Ludgers9, Brotherson10 and many other authors 
tried to explain the incidence, characteristics, pathophysiology, signs, and 
symptoms of these sore lesions. At that time histological knowledge did not 
exist and they recognized and recorded the examination mostly postmortem. In 
the late 19th century Diesterweg11 reported a case of polyps of the posterior 
uterine wall. Indeed, Cullen12 made his first observation from 100 cases, which 
he called adenomyoma. In 1894 and 1896 he drew the conclusion that 
glandular inclusions found in adenomyoma derived from the mucous 
membrane of the uterus. Von Recklinghausen13,14,15 in his 3 publications (1893, 
1895 and 1896) made detailed descriptions of adenomyomata. He 
distinguished between extrauterine and intrauterine adenomyomata. However, 
in his view only cases arising within the uterine wall possessed the same 
structure as the uterine mucosa. Iwanoff16 claimed the first adenomyoma 
evaluation in his Russian papers. The origin and nature of the endometriosis 
glands had been discussed differently as early as 1895 by Orloff17 and 
1
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continued by Mayer18 in 1903. This theory was supported by Schickele19 in 
1904. He stated that the mucosal growth was of mesonephric origin. As late as 
1918 Lockyer20 discussed the various theories on the origin of endometriosis 
found outside the uterine cavity. He considered a serosal origin of this 
endometriosis in his book. Russel21 described endometriosis as adhesions from 
the broad ligament with the right ovary. Russel21 considered the endometriosis 
tumors as due to the presence of aberrant portions of the Müllerian duct in the 
ovary. Semmelink and De Joselin de Jong22 in 1905 presented a case of 
ovarian endometrioma. They decided that the tumor was of Wolffian duct 
origin. Noris23 reported the case of a 29-year-old woman with severe pelvic 
pain. He discussed the possible origin of the endometrial cells and believed 
that the endometriosis was of Müllerian duct origin.  
 
In 1903 Cullen24 published a summary of 19 cases of adenomyoma of the 
uterus. This time he was able to determine that in most cases the glands 
originated from the epithelium lining the uterine cavity. Cullen25,26 published 
other summary papers in 1919 and 1920. He presented a comprehensive 
review of all his findings, reporting the heterotopic presence of the uterine 
glands and stroma almost ubiquitously in the lower abdomen, uterus, including 
the ovary (Figure 11.1). He believed that the uterine mucosa on the surface of 
the ovary and lower abdomen was due to an overflow of the adenomyoma of 
the rectovaginal septum. With the knowledge provided by Cullen’s 
research12,24,25,26,27, Sampson28,29 in 1921 and 1927 accomplished two 
publications, which were considered as the discovery of endometriosis and 
provided the first theory on the pathogenesis of the disease.  
 
Sampson was to contribute more to our knowledge of endometriosis than any 
other individual before or since, earning him the sobriquet “Father of 
Endometriosis”30.  
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1.3.  Epidemiology 
 
The actual prevalence of endometriosis in the general population is still 
unknown31, since laparoscopy or laparotomy is required to make a definitive 
diagnosis. An earlier estimate of the prevalence of chronic pelvic pain (which 
is the main symptom of endometriosis) in the United States based on audits of 
referrals to gynecologic clinics, accounts for 2-10% of the outpatient 
gynecologic consultations and is the indication for approximately 20% of 
laparoscopies31. Based on the few reliable data, the prevalence can reasonably 
be assumed to be around 2-10%32,33,34,35. 
The incidence of endometriosis in Japanese women has been reported to be 
twice that of Caucasian women36. There is a clinical impression that blacks 
have lower rates of endometriosis and Orientals have higher rates than whites37 
(Table 11.1 - Appendix). About 5% of endometriosis cases are seen in 
postmenopausal women, which are caused by hormone replacement therapy38. 
In very rare cases, men undergoing long-term estrogen therapy may also be 
affected38.  
 
1.4. Pathogenesis and pathophysiology  
 
Up to now, more than three theories of pathogenesis of endometriosis have 
been proposed: 
 
1. Metastatic theory39,40,41,42. 
It is the most widely accepted theory that endometriosis results from 
metastatic implantation, particularly retrograde menstruation39. This theory 
also explains the vascular and lymphatic spread of endometriosis. It was 
suggested for the first time by Sampson in 194040. The theory assumes a 
transport mechanism of endometrial tissue from the uterine cavity into the 
peritoneal cavity in a retrograde fashion. The endometrial cells remain 
viable and implant themselves on the serosal layers. Up to 90 % of normal 
women have shown bloody peritoneal fluid during the menstrual 
periods41,42. Some observers showed that the shed of endometrium had 
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growth potential in vitro and that viable endometrial cells can remain in the 
peritoneal fluid. Most women have equilibrium between the development 
of minimal peritoneal lesions and the capacity of the abdominal cavity to 
resorb the endometrial tissue present in the abdominal cavity.  
 
2. Metaplastic theory43,44 
In contradiction to the metastatic theory is the metaplastic theory of serosal 
surfaces (coelomic epithelium) or Müllerian remnant tissue. This was 
suggested by Meyer43 in his publication of 1919. Both endometrial and 
peritoneal cells are derived from the epithelium of the coelomic wall. The 
theory suggested the possibility of peritoneal cells differentiating into 
functioning endometrial tissue. According to this hypothesis endometriosis 
arises as a result from secondary stimulation of inflammation or hormonal 
influences. Based on studies in the rabbit it is suggested that substances 
liberated by the endometrium could induce endometriosis-like lesions in 
the undifferentiated mesenchyma. More recently it is shown that ovarian 
endometriotic lesions are able to arise as a process of metaplasia from the 
ovarian surface epithelial/mesothelial cells in the presence of endometrial 
stromal cells and estradiol44. 
 
3. Induction theory45 
This is a combination of both theories. It suggests that substances released 
from shed endometrium induce undifferentiated mesenchyma to form 
endometriotic tissue45.  
 
4. Immunological theory46,47 
The ability of endometrial implants to survive in ectopic locations may be 
related to an aberrant immune response. The theory of an altered immune 
system and endometriosis suggests that changes in cell-mediated immunity 
and humoral immunity may contribute to the development of the disease46.  
The pathophysiology of immune alteration and endometriosis was depicted 
by Berkkanoglu and Arici (Figure 11.2 - Appendix)47.  
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5. Environmental theory48,49,50,51,52 
In 1993 Rier48 and her colleagues found that rhesus monkeys exposed daily 
to 5 or 25 parts per trillion (ppt) of dioxin for 4 years developed 
endometriosis, with incidence and severity related to dose. It was also 
shown in research for deficiency in genes responsible for dioxin 
detoxification, which may predispose women to endometriosis49,50. 
Dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, TCDD) and structurally 
related congeners (polychlorinated dibenzo-p-dioxins, called dioxins) are 
families of chlorinated aromatic hydrocarbons (Figure 11.3 - Appendix)51.  
Exposure to dioxins occurs mainly through dietary exposure. The 
pathogenesis of predisposing women to endometriosis is plausible by 
altered production of various cytokines and growth factors, by remodeling 
of endometrial tissue through effects on the expression and activity of 
matrix metalloproteinases and the tissue inhibitors of matrix 
metalloproteinases, by promoting angiogenesis, or by compromising the 
immune system52. 
 
6. Genetic theory53,54,55,56,57  
There is increasing evidence that endometriosis is inherited as a complex 
genetic trait in which multiple genes conferring disease susceptibility 
interact with each other and with the environment to produce the 
phenotype. Research groups worldwide are trying to identify such 
susceptibility genes through a positional cloning approach53. Evidence for 
a genetic basis comes from case reports of concordance in monozygotic 
twins55,56 and a study of monozygotic and dizygotic twin pairs from the 
Australian National Health and Medical Research Council Twin Register57.  
 
1.5.  Signs and Symptoms 
 
Clinical presentation of endometriosis is associated with a wide variety of 
symptoms, although in many patients it is asymptomatic. There is no 
pathognomonic symptom for this disorder, thus making the diagnosis of 
endometriosis difficult. Most risk factors for endometriosis relate to a concept 
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of condition that is estrogen-dependent and associated with reflux of menstrual 
fluid to the peritoneal cavity. The risk of endometriosis seems to be dependent 
on the amount of menstrual flow. Endometriosis is more common in women 
with a short menstrual cycle (≤27 days), and longer menstrual flow (≥7 days) 
and spotting before onset of the menses58,59,60. A decreased likelihood of 
endometriosis has also been observed in women who have been pregnant. The 
risk of endometriosis is inversely related to the number of pregnancies61,62. A 
positive family history of endometriosis is relevant since there is growing 
evidence suggesting that a genetic component plays a role in endometriosis, 
probably involving a polygenic pattern of inheritance63,64,65. There is 
significant familial clustering, and first degree relatives of women with 
endometriosis have a sevenfold greater chance of having endometriosis66,67. 
Associations between red hair, dysplastic nevi and endometriosis have been 
reported68,69.  
 
The most important symptoms of endometriosis are infertility and chronic 
pelvic pain. In the population of infertile women undergoing surgical 
intervention, the rate of endometriosis is higher than in fertile control women 
(14%)31. But the prevalence of infertile women among the endometriotic 
patients has not been precisely evaluated. In women with pelvic pain, 
endometriosis was detected at the time of surgery in 19%31. The pelvic pain 
typically consists of dysmenorrhea, intermenstrual pain and dyspareunia. 
Although dysmenorrhea is not predictive of endometriosis, it is the most 
commonly reported symptom, and its severe form is highly suggestive of 
endometriosis70. Dysmenorrhea is usually progressive, with the onset of pain 
often preceding the onset of menstrual flow. It usually continues throughout 
the menses and occasionally persists for several days afterwards. The pain is 
most often localized in the lower abdomen and deep pelvis. It is bilateral, often 
radiating to the back and thighs. It is often described as dull and aching and 
may be associated with rectal pressure, nausea and episodes of diarrhea71. 
Intermenstrual pain may exist after the dysmenorrhea, and in very severe cases 
patients may suffer from pain throughout the cycle. Endometriosis-related 
dyspareunia is usually positional and most intense upon deep penetration. 
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Dyspareunia was found more in the rectovaginal (100%) form than in the 
ovarian (77%) or peritoneal form (88%)72. It is most intense prior to 
menstruation, but in severe cases it may preclude intercourse throughout the 
month. Dyspareunia is usually associated with endometriosis of the cul-de-sac 
and rectovaginal septum73.  
 
Endometriosis has been found in extrapelvic organs (e.g. intestinal tract, 
urinary tract, surgical scars, lungs, thorax, peripheral nerves and the central 
nervous system). Consequently, patients may have symptoms with cyclic and 
menses-aggravated cyclic bleeding and inflammation. Hepatic endometriosis 
may present with cyclic right-sided subcostal pain. Endometriosis of the 
urinary tract can cause hematuria, dysuria, urgency and frequency of urination. 
Involvement of the ureter may cause flank and iliac fossa pain due to partial 
ureteric stenosis. Pleural and pulmonary endometriosis may be manifested by 
hemophthysis, chest pain, and shortness of breath. Cerebral endometriosis can 
lead to perimenstrual headaches or even seizures74.  
 
Symptomatic endometriosis after the menopause is rare and usually related to 
hormone replacement therapy75. Nevertheless, cases of de novo endometriosis 
in postmenopausal women have been described76. 
 
1.6.  Diagnosis 
 
The currently available diagnostic tools have not only advantages but also 
limitations. Despite an extensive research for new laboratory tests and 
advances in imaging technologies, at present there are no simple noninvasive 
diagnostic tests and endometriosis still remains an enigmatic condition.  
 
a. Physical examination 
Physical findings for endometriosis are nonspecific. Pelvic examination 
should be performed during the menses because the sensitivity of the 
examination is higher than at any other time during the menstrual cycle1,31.  
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b. Radiologic evaluation 
Not unexpectedly, radiologic evaluation of small endometriotic implants is 
limited. Therefore, the radiologic findings play an important role in 
identifying and evaluating an endometriotic cyst39.  
b.1.  Ultrasonography31,39,77,78,79,80 
The role of ultrasonography is limited to detecting endometriotic 
cysts of the ovary but not adhesions or superficial implants31,39,77,78. 
However, both transabdominal and transvaginal approach should be 
performed.  
Transabdominal ultrasound is useful to detect bladder or abdominal 
wall endometriosis. Transvaginal ultrasound should be performed 
preferably to evaluate the cul-de-sac and cysts. The diagnostic 
accuracy of ultrasound has been reported to have up to 92% 
sensitivity and 99% specificity79,80.  
b.2.  Doppler examination81 
There is controversy regarding the vascular presence of 
endometriomas. Alcazar81 found that in patients with pelvic pain, 
vascularization of ovarian endometriomas is higher and the pulsatility 
index is lower than in asymptomatic patients. Improvement in 
diagnostic accuracy may be achieved with the introduction of power 
Doppler, which allows detection of low-velocity flow. 
b.3. Three-dimensional ultrasound82,83 
Applications of three-dimensional ultrasound in detecting cystic 
ovarian tumors have been reported82,83.  
b.4.  Magnetic resonance imaging39,84,85 
MRI has been shown to have greater specificity for the diagnosis of 
endometriomas than other noninvasive imaging techniques. 
Occasionally it may also visualize solid endometriotic implants and 
adhesions because of better visualization of the surrounding anatomic 
structures. In addition to using routine T1-weighted and T2-weighted 
pulse sequences, a T1-weighted fat-suppressed sequence should be 
performed to accentuate the difference in tissue signal. 
Endometriomas have relatively homogenous high signal intensity 
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(similar to or greater than fat) on T1-weighted images. With removal 
of surrounding fat, the recognition of conspicuous lesions is 
improved. Lesions with degenerated blood products, including 
methemoglobin and concentrated protein, appear with high-signal 
intensity areas on T1- and T2-weighted images. A common and 
important feature of an endometrioma is “shading” (loss of signal 
within the lesion), which can be seen on T2-weighted images39. 
Togashi et al.84 found that a “definitive” diagnosis of an 
endometrioma was made when a cyst was hyperintense on T1-
weighted images and shading on T2-weighted images (sensitivity of 
90% and specificity of 98%).  
MRI demonstrates high sensitivity, specificity, positive and negative 
predictive values, and accuracy in predicting the locations of 
extension of disease in patients with deep pelvic endometriosis85. 
 
c. Tumor markers86,87 
An elevated CA-125 (cancer antigen 125) level in peripheral blood has 
been described. Several studies performed in a population at high risk for 
endometriosis have demonstrated that serum CA-125 has good specificity 
(86-100%) but poor sensitivity (13%)86. Table 11.3 (Appendix) shows a 
summary of multiple markers for endometriosis (from Bedaiwy87). 
 
d. Laparoscopy88 
Up to now, laparoscopic assessment in combination with histological 
examination remains the gold standard for the definitive diagnosis of 
endometriosis. More than 60 years ago, Sampson28,29 described pelvic 
endometriosis by using terms such as red raspberries, purple raspberries, 
blueberries, blebs and peritoneal pocket. Knowledge of the most common 
location of endometriosis is nowadays required for accurate visual 
inspection of the pelvic and abdominal cavity during laparoscopy. The 
typical appearance of endometriosis is often made up by classical powder 
burn, puckered black or bluish lesions88. There are three different forms of 
endometriosis that must be considered in visual inspection during 
 
Endometriosis-associated Pain, Social Impact, and Information through Internet Survey 
 
 
10
laparoscopy: peritoneal implants (Figure 11.4 - Appendix), endometriomas 
(Figure 11.5 - Appendix), and deep infiltrating lesions (Figure 11.6 - 
Appendix). The latter nodules are difficult to examine during laparoscopy. 
However, meticulous palpation using the laparoscope probe may identify 
these lesions. 
On the other hand, lesions associated with hemangiomas, old sutures, 
necrotic areas from ectopic pregnancies, cancer cells, epithelial inclusions, 
residual carbon from previous laser surgery, hysterosalpingogram dye 
reaction and inflammatory cyst may be mistaken for endometriosis.  
 
e. Pathology 
The classic endometriotic lesion has a diffuse mixture of glands, stroma, 
intraluminal debris and fibromuscular scarring. It may be confused with 
fibrotic tissue from previous inflammatory disease or postoperative 
scarring in white lesions of endometriosis.   
 
f. Staging of endometriosis. 
The American Society for Reproductive Medicine has published a revised 
classification of endometriosis in 199789. It is shown in Figure 11.7 - 
Appendix.  
Keckstein90 has proposed a new scoring system called “ENZIAN-Score” as 
an addition to the r-AFS Score for deep infiltrating endometriotic lesions.  
 
1.7.  Differential diagnosis 
 
Differential diagnosis of endometriosis is grouped according to the organ 
system1,91: 
a. Genital area: pelvic inflammatory disease, pregnancy complication, 
adnexal masses 
b. Gastrointestinal tract: hernia, abdominal walls trigger points, irritable 
bowel syndrome, lactose intolerance, constipation, gastrointestinal 
malignancy, diverticulitis, diverticle 
c. Urology: interstitial cystitis, bladder stone 
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d. Orthopedics: fibromyalgia, spondylosis, hernia of the nucleus pulposus 
e. Pelvic pain of undetermined etiology (tension from pelvic muscle, eg. 
cramp of the levator or piriform muscle), psychological factors.  
 
1.8. Treatment 
 
The efficacy of medical and surgical treatment of endometriosis is a source of 
questions and controversies. A complete resolution of endometriosis is not yet 
possible92. Moreover, ectopic endometrium can proliferate under hormonal 
influence after a long time without estrogens93. Therefore, therapy should be 
directed to three essential outcomes: reduction of pain, increasing of the 
pregnancy rate, delay of recurrence as long as possible92.  
 
a. Medical therapy 
 Medical therapy plays a role in the therapeutic strategy when administered 
over a prolonged period of time. Given their good tolerability, minor 
metabolic effects and low cost, progestogens must therefore be considered 
as drugs of choice and are currently the only safe and economic therapy to 
surgery94. 
a.1. Danazol 
Danazol is a derivative of 17α-ethinyl testosterone. The 
recommended danazol dosage for treatment is 600 to 800 mg/day. 
Although a small number of studies of lower dosage of danazol show 
relief of endometriosis-associated pain95, the use of danazol is of 
limited value96. 
a.2. Progestogens 
The mechanism of progestogens is to decidualize the endometrial 
tissue followed by atrophy. There is evidence suggesting that another 
mechanism of action at the molecular level is the suppression of 
angiogenesis and matrix metalloproteinases, enzymes that are 
important in the implantation and growth of ectopic endometrium97. 
The most extensively used progestogen is medroxyprogesterone 
acetate (MPA). The dose ranges from 20 mg to 100 mg daily and 150 
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mg as 3 monthly depots96. Side effects are generally well tolerated 
(e.g. breakthrough bleeding due to hypoestrogenemia, nausea, breast 
tenderness, fluid retention, depression)98. Breakthrough bleeding can 
be corrected by short-term administration of estrogen98 or increase of 
the progestogen dose96. Other progestogens, e.g. levonorgestrel, can 
be utilized via an intrauterine delivery system and are effective for 
the treatment of rectovaginal endometriosis99.  
a.3. Oral contraceptives (combination estrogen-progestogens) 
The mechanism is believed to decidualize the endometrial tissue and 
followed by atrophy. Oral contraceptives suppress proliferation and 
increase the abnormally low apoptotic activity of the endometrium of 
women with endometriosis94,100. Moreover, anovulation, 
decidualization, amenorrhea and the establishment of a steady 
estrogen-progestogen milieu contribute to the quiescence of disease.  
a.4. GnRH agonist 
Gonadotropin-releasing hormone (GnRH) agonists are modified 
forms of GnRH that bind to the pituitary GnRH receptors and remain 
for a long time. They are thus identified by the pituitary as rapidly 
pulsatile GnRH, and after initial stimulation of follicle-stimulating 
hormone (FSH) and luteinizing hormone (LH) secretions, result in a 
down-regulation of pituitary gonadotropin secretion. The end result is 
a lack of ovarian stimulation and a hypoestrogenic milieu similar to 
the postmenopausal situation. It is also postulated that the GnRH 
agonist alters plasminogen activators and matrix metalloproteinases, 
factors important in the development of endometriosis101. The side 
effects include complaints in the postmenopausal situation (e.g. hot 
flushes, decreased libido, breast tenderness, insomnia, depression, 
irritability, osteoporosis, and decreased skin elasticity). A 
modification of GnRH agonist treatment is to add back small 
amounts of steroid hormone, based on the theory that the estrogen 
level needed by endometriosis is higher than that of estrogen needed 
by the brain, bone and other tissues102.  
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a.5.  Gestrinone (ethylnorgestrienone, R2323, an antiprogestational 
steroid)96  
a.6. Mifepristone (progesterone antagonist) and selective progesterone 
receptor modulators (progesterone agonist-antagonist)96 
a.7. Selective estrogen receptor modulators (Raloxifene)96 
a.8. GnRH antagonists96 
a.9. Aromatase inhibitors (e.g. anastrozole)96 
a.10. Other experimental medication96 
With a growing understanding of the pathogenesis of endometriosis, 
more precise molecular targets for treatment have been identified (e.g. 
TNF-α inhibitors, angiogenesis inhibitors, pentoxifylline, matrix 
metalloproteinase inhibitors). Thus, these medications are still under 
development and promise a greater efficacy and flexibility than 
traditional treatments.  
 
b. Surgical management 
Because of the lack of prospective, randomized and controlled studies, firm 
conclusions regarding optimal treatment are difficult103. The treatment 
objectives are to restore normal anatomy, to remove or ablate endometrial 
implants, and to prevent or delay recurrence of the disease. Surgical 
treatment has been more commonly effected by the laparoscopic approach 
since the development of advanced laparoscopic equipment and operative 
techniques. In moderate or severe endometriosis with anatomic distortion 
of the pelvis, surgical treatment is still the first line treatment to maintain 
or restore fertility. 
 
Surgical principles 
The principle in surgical treatment is the removal of all endometrial 
implants in an atraumatic, hemostatic fashion in the least amount of time. 
Adhesions are excised rather than simply lysed because of the possible 
presence of endometriosis within adhesions. Reduction of tissue 
desiccation and maintenance of a clean surgical field are facilitated by 
copious irrigation with physiologic fluids. The operative success rate 
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correlates with meticulous surgical techniques that maintain serosal 
integrity and decrease the risk of de novo formation of adhesion. 
Adamson103 has summarized the surgical principles in the treatment of 
endometriosis (Table 11.4 - Appendix). Although the laparoscopic 
approach is preferred for surgery, it is always important to obtain the best 
result even by performing a laparotomy if necessary. Elimination of 
endometrial implants may be accomplished by laser ablation, 
electrosurgical dissection or sharp resection.  
 
c. Pre- and postsurgical management  
In case of minimal or mild endometriosis-associated infertility, the use of 
coagulation, laser, excision or adjuvant medical therapy in combination 
with laparoscopic surgery is still under debate104. Laparoscopic destruction 
was proven to be the first line therapy105. In case of moderate and severe 
endometriosis-associated infertility, medical therapy alone is not effective. 
In a study of 814 women with ovarian endometriomas, the authors 
obtained a cumulative pregnancy rate of 51% after combined treatment 
with GnRH-agonist and laparoscopic surgery. The pregnancy success 
occurred within 10 months after surgery106.  
In case of endometriosis-associated pain, surgical treatment alone has an 
unsatisfactory result in treating the pain. But medical treatment alone has 
also an unsatisfactory result in the management of pain. Waller107 reported 
that the cumulative recurrence rate for the five years after 6 months of 
GnRH-agonist alone therapy was 53.4% (36.9% for minimal disease and 
74% for severe disease). Therefore, postoperative adjuvant medical 
treatment, causing hypoestrogenism and amenorrhea might delay the 
recurrence of symptoms108,109.  
 
d. Alternative therapy (complementary care) 
An increasing number of women with endometriosis are turning to 
complementary or alternative therapies. They experience relief of the 
symptoms with modifications to their diet, lifestyle changes, naturopathic 
remedies, and self-nurturing behavior (yoga, massage, qi gung, 
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acupuncture). These activities help them to achieve a sense of control over 
their lives and a reversal of the control that endometriosis had over them110. 
Ayurveda 
Ayurveda is one of the oldest therapeutic methods. It comes from the 
ancient Hindus and might still be applicable in western medicine. Its 
therapeutic concept is based on 5 ground elements: air, wind, fire, water 
and earth111. 
Homeopathy 
In the 18th century, Dr. Samuel Hahnemann pioneered homeopathy in 
Germany. He discovered chemical substances that act in healthy humans as 
poisons but in pathologic situations (diseases and disorders) act as 
medications112. 
Acupuncture  
It is based on traditional Chinese medicine (TCM). In acupuncture it is 
believed that the needles correct any imbalances in the flow of life force 
along meridians. In contrast, many western medical, nursing and 
physiotherapy staff believe that the needles stimulate the nervous system in 
a particular way. Acupuncture may also produce effects through local 
changes in the tissues, e.g. stimulating blood flow. Acupuncture and 
acupressure appear promising for dysmenorrhea but further studies are still 
needed113. 
 
1.9.  Social support for patients with endometriosis 
 
Chronic endometriosis is notoriously difficult to treat and many women 
become frustrated with their health114. In an endometriosis center treatment 
must be integrated in one concept. Extended knowledge about the medical 
treatment and experienced operators (laparoscopy) must be the first 
requirements for an endometriosis center. Adding a cooperation venture 
between the gynecologist, a patient support group, and the Endometriosis 
Association would complete the whole therapy concept. These patients should 
be encouraged to develop a supportive network of friends, family and co-
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workers. The most supportive sources tend to be other women with the same 
disease, endometriosis110.  
 
1.10. Problems in endometriosis 
 
Women with chronic pelvic pain, infertility and dysmenorrhea try to search for 
information about their problems. They should get reliable and competent 
information and have early awareness to search medical help. This information 
can be transferred passively by media, papers, internet, etc, or be delivered by 
relatives, friends, even directly by the medical staff. The information should be 
reliable, accurate, up-to-date, easy to understand, and available in many public 
medical centers. It takes time to analyze and discuss information until the 
women make their decision, whether they continue to find medical help. After 
the decision making, most of them continue to visit a medical expert. Decision 
is becoming more difficult as they have to decide whom they have to consult. 
The surgeon, internist, gynecologist or urologist may come to be a choice. 
After hearing the first opinion of one expert, most women are going to another 
specialist to obtain a second opinion. Finally, these women come to a 
gynecologic practice. Here we must face the fact that the diagnosis of 
endometriosis remains challenging. The “gold standard” diagnostic tool still is 
laparoscopy with histological examination.  
 
The uncertainties surrounding the diagnosis and management of endometriosis 
often leave the patient in pain, feeling confused by the limited information 
provided by her doctor and with a mixed bag of emotions: fear, grief, anger 
and a feeling of self-guilt being prominent among them115. An open, mutually 
understanding relationship between doctor and patient is necessary if the 
diagnosis is to be made without undue delay. Appropriate management will 
then include that the doctor takes time to explain the condition and its 
associated uncertainties, to discuss the treatment options, and to forewarn 
about possible side-effects115. 
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Therefore, women affected by endometriosis claim that delayed diagnosis is a 
great problem116. Some studies have shown that the delay in diagnosis of 
endometriosis is around 7 years (Table 11.6 - Appendix). Ballweg117 has 
summarized that the delay in the diagnosis of endometriosis (from over 7000 
confirmed cases) is on average more than 9 years. Nevertheless, endometriosis 
is a major problem and current treatments are far from satisfactory117. 
Misdiagnosis and underdiagnosis of endometriosis are not only due to the 
limitations of diagnostic tools but also to a lack of recognition of the symptoms 
by the patients and physicians31.  
 
The impact of endometriosis, a disease that already produces intense 
symptoms, is worsened by a current lack of understanding of the disease 
beyond its pelvic definition117. Denny118 conducted a study to explore 
women’s experience of endometriosis. Despite the existence of severe pain, 
their symptoms were frequently trivialized or normalized. The pain is huge and 
often described as overwhelming or intense and can only be managed with 
over-the-counter pain killers. There were also instances of vomiting or fainting 
when the pain was at its worst. Dyspareunia was experienced as a sexual 
difficulty and could strain the relationship and marriage. In the work and social 
relationship endometriosis also has negative effects. Women explained that 
their social life was curtailed because they missed many social events. They 
expected more support from friends and family to understand their condition. 
The experiences in the workplace were quite diverse. Living with severe pain 
usually entailed taking some sick leave, or being unable to perform the job 
adequately, while the taking of strong analgesics limited the type of work they 
could do. Women with endometriosis must face the fact that they have to 
resign from work118. 
 
The economic correlation between chronic pelvic pain and endometriosis has 
also been reported by a few studies119,120,121,122. In the United Kingdom, 
Davies119 estimated the annual costs of intractable gynecologic pain at £158.4 
million for women with either endometriosis or no recognizable disease. 
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Mathias120 calculated that the annual direct cost for visits to the physician 
because of chronic pelvic pain was estimated to be $881.5 million.  
 
Beyond all of these problems, help for women with chronic pelvic pain, 
dysmenorrhea, infertility or even endometriosis is needed. This help should 
include: right and current information, correspondence with other women with 
the same problems, discussion with experts. These three points must be 
available anytime and anywhere and should also be supported by many experts. 
Nowadays, the preferable platform is an internet Web site. Through an internet 
Web site, information can be accessed 24 hours a day, connected to other 
endometriosis-based Web sites, and is easy to update. Information about the 
definition, symptoms, signs, examinations, treatments, and rehabilitations 
should be provided. A possibility to communicate with experts could also be a 
satisfaction. The doctors, nurses, and other health providers are the persons 
who introduce the Web sites to their patients. The patients are sensitized to the 
Web sites through brochures, seminars, invited to “Health Talks”, and by 
advertisement in the private praxis. During surfing and browsing the internet 
Web sites, the visitors are asked to participate actively in a discussion, chat 
forum, teleconference, and correspondence with one or more experts. They try 
a so-called endometriosis test through Web sites. With this test, the possibility 
of endometriosis is predicted by collecting the symptoms and signs of patients. 
They would get a reply after finishing the test and thereafter the attention about 
the seriousness of their problems will arise. These women seek the health 
providers earlier to consult about their endometriosis-associated complaints.   
 
One way of patient information about endometriosis, based on an internet Web 
site, is www.endometriose.de. Here, women can get information about 
endometriosis. Information about the diagnosis, symptoms, signs, therapy, 
seminars, and social groups are explained and discussed in detail. On this Web 
site the browsers can fill out a questionnaire called “EndoTest”. This test is 
aimed at collecting the women’s common complaints and at predicting the 
possibility of endometriosis derived from the severity of the problems. At the 
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end of the questionnaire, the assessment of quality of life, encompassing 
physical, psychological and social aspects, can be obtained.  
 
Increasingly, consumers access the internet for information about their health 
problems and treatments. Some browse the internet only to learn more about 
their health care. The information provided at health Web sites, unfortunately, 
is often inaccurate, incomplete, or biased, and may even evoke a potential risk 
to the person’s health123,124,125. In recent studies, many tools were developed to 
evaluate health-related Web sites, e.g. HITI126, HON Foundation127, URAC´s 
Health Web Site Accreditation128, Criteria developed by the American Public 
Health Association129 and the American Medical Association130. Seal approval 
would be given to the Web site meeting the standards for health information. 
With major search engines (Lycos, Yahoo, Google, Netscape) more than 
900.000 Web sites were found131 (Accessed on September 26, 2004). To date, 
there are limited studies to evaluate and examine the quality of Web sites on 
endometriosis. In this paper, 20 Web sites on endometriosis were evaluated 
based on standard criteria in assessing the quality of health information on the 
internet. 
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QUESTIONS 
It is the aim of this investigation to collect more information in the area of 
endometriosis-associated pain and its social impacts. Since the internet has become a 
very popular medium to easily and anonymously access forums and chat rooms with 
specific topics, research was undertaken to find out information about those 
searching advices and also what specific information is wanted. The following 
questions have been specifically investigated: 
 
1. What kind of information do women with pelvic pain, dysmenorrhea, 
infertility, and dyspareunia need while searching medical help? 
2. How many women in the studied population have chronic pelvic pain and 
what is the level of pain? 
3. How many women in the studied population have dysmenorrhea? 
4. How many women in the studied population have dyspareunia? 
5. And how many women in the studied population have infertility? 
 
And further questions about the impact of these problems: 
 
6. How far do these problems interfere with the quality of life? 
7. How far do these problems interfere with productivity? 
8. How big is the economic burden from endometriosis-associated impacts?  
9. How many women can be suspected to have endometriosis as the cause for 
their pelvic pain on the basis of the symptoms? 
10. What kind of information about endometriosis is provided on Web sites?  
11. Which Web sites meet the standard criteria and are appropriate for most 
patients? 
 
 
 
2
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MATERIAL AND METHODS 
A Web site for endometriosis, www.endometriose.de, has been developed in order to 
provide online-information for the public. On this site complete information on 
endometriosis is available. The page is mainly written in German and it has also a 
feature to switch the language into Greek, English, Turkish, Polish, and Russian. 
Every single language has at least one special contact partner who understands the 
language well. The browser is welcomed with a banner “When you have abdominal 
pain, menstrual pain with infertility, it could be caused by endometriosis“. Moreover, 
the preface tries to show how important endometriosis is to women who have 
periodical pain and chronic abdominal pain. At the end of the preface, the readers 
are reminded that this information is an additive to consultation of the physician. 
 
On the further sites, visitors can read more details about endometriosis. Definition 
and pathogenesis are described in detail and without using any medical terms. The 
two main theories about the pathogenesis of endometriosis are discussed. The 
readers are expected to realize that the cause of endometriosis is still unknown and 
that the environment and life style could play a big role in the pathogenesis. On the 
next page, the main symptoms of endometriosis are shown, which are mostly 
abdominal pain and infertility. The abdominal pain includes cyclic pain 
(dysmenorrhea), pain during sexual activity (dyspareunia), and chronic abdominal 
pain. A check list of the pain rhythm is available to help women in the preparation 
before consultation of the physician. The explanations of the pathogenesis of 
endometriosis in infertility are also discussed. The readers are sensitized to know 
more about the main problems in infertility and not to forget that the cause of 
infertility may be on the male side. The diagnosis of endometriosis is also explained 
in clear detail, beginning with anamnesis, gynecologic examination, ultrasound 
examination of the pelvis, and laparoscopic diagnosis. Three therapy options are 
discussed, including surgical, medical and alternative therapies. Laparoscopic and 
laparotomic approaches by different techniques using scissors, high frequency 
instruments, and lasers are discussed as surgical therapy. Rehabilitation is integrated 
3
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in the whole management of endometriosis, and most rehabilitation measures are 
undergone after surgical treatment has been finished. At the end of the journey the 
browsers can find the names of 14 experts who supported the Web site (List of 
names is shown in Table 11.7 - Appendix).  
 
Neither registration before nor entering password and login name are needed to 
browse the whole Web site. It can be accessed 24 hours a day and 7 days a week. On 
the main page the latest news and the latest programs from the European 
Endometriosis Information Center (EEIC) are displayed. 241,393 visitors were 
registered from May 2003 until September 2004. The complete register is shown in 
Table 11.8 - Appendix. In this study the data is limited to 29 July 2004.   
 
3.1.  Data input 
 
3.1.1. Discussion forum 
 
 On the main page of www.endometriose.de, the visitors are invited to 
join the discussion forum by a banner “ask directly our experts in 
Online Forum”. The patients can address their questions either directly 
to a specific reference or just at a pool. From this pool, the questions 
are then distributed to 14 different references. One expert is responsible 
to answer the questions in one month.  
 
 The correspondent may choose the topic by herself, and with the help 
of this topic she can write the questions. With permission from the 
respondent the questions can be accessed by the others with a search 
engine. The topics of discussion, chosen by the EEIC are: 
1. Lower abdominal pain  
2. Infertility 
3. Hormonal therapy  
4. Surgical therapy  
5. Alternative therapy  
 
 
Endometriosis-associated Pain, Social Impact, and Information through Internet Survey 
 
 
23
6. Follow-up after operation 
7. Diagnostics 
8. Sterility 
9. Pain therapy 
 
Not only one question may be addressed in one letter; most of the 
letters contained a series of questions with information about the 
previous history. Open questions are generally used. The responsible 
experts for the month answer the questions in detail, individually, and 
within a short time. The experts can ask questions in return if more 
information is needed from the patients. Other people seeking a similar 
answer can get the published forum directly through the search engine. 
Husbands may also write in the discussions forum if their wives have 
endometriosis problems. Published discussions can be found by an 
internal search engine. By searching the topic and clue question, 
discussion themes can be easily found.  
Each correspondence letter is summarized based on the core of the 
question and its answer. It is classified into subgroups. These 
subgroups are shown in Table 3.1.1. 
 
Table 3.1.1. Subgroups of discussion themes 
Main groups Subgroups  
Abdominal pain Pain treatment 
Bowel or bladder endometriosis and distant metastasis 
Psychological effects 
Infertility Chance of pregnancy 
Pregnancy under hormone therapy 
Fertility after surgical therapy 
Hormonal therapy 
 
Side effects 
Tailoring of hormonal therapy 
Surgical therapy 
 
Indication of surgical treatment 
Tailoring of surgical treatment 
Follow-up Follow-up after surgical therapy 
Follow-up after medical treatment 
Alternative therapy  
Diagnostics  
Abnormal bleeding  
Endometriosis center  
Cost and insurance  
Recurrence  
Pathophysiology and pathogenesis   
Miscellaneous  
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3.1.2. Questionnaire 
 
At the beginning of the Web site, respondents are warned again that 
this test can only suggest the presence of endometriosis without giving 
any diagnosis. The respondents are also advised to consult the 
gynecologist when they have any symptoms or complaints. Endo-Test 
is not aimed to prove a diagnosis of endometriosis, but when the 
diagnosis is not achieved this test should be a guide leading to the 
diagnosis of endometriosis.  
  
The guidelines to fill out the questionnaire can be seen on the first page 
at the beginning of the Endo-Test. At the end, the test is calculated and 
the respondents obtain the result directly. They can give their email 
address if the report of the test is requested.  
 
A total of 12 closed questions was developed and prepared as a 
questionnaire in HTML format. Respondents click the buttons for each 
point of the questions. The first part of the questionnaire includes 6 
questions which refer to symptoms and signs of endometriosis. The 
Discussion forum 
9 Themes 
 
 Abdominal 
pain 
Infertility Hormonal 
therapy 
Surgical 
therapy 
Alternative 
therapy 
Diagnostics
Follow up 
Sterility 
 
Pain 
therapy 
Respondents/Browser/
Family/Patients 
Reference: Team of 14 experts 
Unpublished 
discussion 
(wished by the 
respondents) 
Figure 3.1.1. Flow chart classification of discussion forum 
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respondents can continue the Endo-Test by pressing the “Analyze” 
button or erase the form. The computer calculates the score. Raw 
scores for this questionnaire were derived from an unpublished study 
by Bühler et al. Based on the total number of points the respondent gets 
directly the calculated probability of endometriosis according to her 
complaints. Table 11.5. (Appendix) presents the scoring process and 
translated questionnaire.  
 
In the second part of the Endo Test the respondents are asked about the 
impact of their complaints, signs, and symptoms on their social 
activities. They can ignore the second part of the questionnaire.  
 
Overall, the Endo Test is aimed at warning the candidate of 
endometriosis by bringing together her chief complaints, symptoms and 
the relevant social effect. The questionnaire contains the following 
items: 
1. Questions about signs and symptoms of endometriosis 
(dysmenorrhea, severity, timing, frequency, dyspareunia, hematuria, 
hematochezia) in the first part of the questionnaire 
2. The relation and possibility of these complaints with endometriosis 
(infertility, contraceptives) 
3. The impact on the candidate’s social activities (energy-vitality, 
interference of pain with sexual activity, physical activity, days of 
reduced activity, reduced productivity at work and time of work 
lost). 
 
Scoring system 
 
Only the first part of the Endo Test was scored. The score system is 
mostly based on the relation of the symptoms, that given by the 
respondents, to endometriosis. The most important symptoms of 
endometriosis are dysmenorrhea, chronic pelvic pain, dyspareunia, and 
infertility. Endometriosis-associated dysmenorrhea is usually 
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progressive, continues throughout the menses, and the onset of pain 
often precedes the onset of menstrual bleeding. Therefore, always 
having dysmenorrhea, pain before the onset of menstrual bleeding, and 
most pain together with the bleeding are associated with a higher score. 
Chronic pelvic pain without any other gastrointestinal problems is also 
associated with endometriosis. The score for frequent chronic pelvic 
pain is higher. Dyspareunia is usually positional and intense upon deep 
penetration. Dyspareunia at the entrance of the vagina is not associated 
with endometriosis, therefore 0 point.  
Endometriosis in extrapelvic organs is associated with cyclic and 
menses-aggravated cyclic bleeding from the affected organ. Taking 
contraceptive pills is in this case related to hormonal treatment in 
endometriosis.  
However the correlation between questionnaires and clinical diagnosis 
of endometriosis should be proven in a further study.  
 
3.1.3. Evaluation of Web sites on endometriosis 
 
Major search engines have been identified: Yahoo, Google, Netscape, 
Excite, AltaVista, MSN, and Lycos. Key words and phrases 
(endometriosis) were then used in each of the search engines. Using the 
combinations, each search engine was evaluated for the relevance of 
the first 20 sites. Relevant URLs were highest selected when the key 
phrase “endometriosis” was used. The Yahoo and AltaVista search 
engines yielded a significant number of relevant URLs (897,000 hits 
and 902,000 hits, respectively) and were chosen as the two search 
engines to be used. This method of identifying Web sites for evaluation 
was consistent with study from Oermann et al.160. Web sites for 
professional purposes, such as continuing education sites, were 
excluded from this search method. Duplicates on the search engines 
were eliminated, and the selection continued down the list for a total of 
20 sites on both search engines. The American Medical Association 
(AMA)130 has published guidelines for medical information on the 
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internet. In our study, the quality of 20 Web sites was assessed 
according to objective scoring scales adapted from the AMA online 
health information guidelines. These objective scoring scales were 
introduced by Huang159. They divided three evaluation criteria (Web 
site ownership, editorial content, and navigation) into subcriteria, and 
gave a score of 1 for each criteria met. There are 7 criteria regarding 
Web site ownership and affiliations, 8 criteria regarding editorial 
content, and 11 criteria regarding navigation. The complete criteria are 
shown in Table 11.11. Web sites with and without seal approval from 
international standards for health information (e.g. HON, URAC´s) 
were compared. The twenty Web sites on endometriosis identified by 
the search engines Yahoo and AltaVista are shown in Table 3.1.3. The 
most relevant Web sites are listed first, followed by other similar pages. 
 
Web sites in this study were classified based on total scores into poor, 
average and good. A score of 0 to 8 was categorized as poor, a score 
from 9-17 was categorized as average, and a score of more than 18 
(maximally 26) was categorized as good. 
 
Table 3.1.3. List of 20 endometriosis-associated Web sites 
1. www.endometriosis.org  
2. www.hcgresources.com/endoindex.html 
3. familydoctor.org/handouts/476.html 
4. www.ivf.com/endohtml.htm 
5. www.womensurgerygroup.com/conditions/endometriosis/overview.asp  
6. www.endometriosispaintreatment.com  
7. www.womensendosurgery.com/endometriosis.html  
8. www.emedicine.com/emerg/topic165.htm  
9. www.endofacts.com  
10. www.endocenter.org  
11. www.endozone.org or www.endometriosiszone.org 
12. endometriosis.allbio.org 
13. www.endometriosisasn.org  
14. www.centerforendo.com 
15. www.nlm.nih.gov/medlineplus/endometriosis.html 
16. www.endo.org.uk 
17. www.endometriose.de  
18. www.endo101.com/index.htm 
19. www.endometriosis.com 
20. www.womenshealthchannel.com/endometriosis/index.shtml 
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3.2. Statistical analysis 
 
All data were administered by Mr. Max Meyn (meyn@blitz.de) in Bamberg, 
who is also the webmaster of www.endometriose.de. From the main data bank, 
records of discussion forum were transferred into comma delimited document 
(csv) and records of Endo-Test were transferred into text format (txt). Both 
CSV file and TXT file were converted into database using SPSS version 12 for 
Windows.  
 
To examine the bivariate association between two variables, cross-tabs with 
Pearson´s chi square test were used. The association between total score and 
endometriosis-associated social impact was tested using the one way ANOVA 
test by comparing the change scores. In terms of probability of endometriosis, 
the categories of endometriosis score and severity of social impact were tested 
with cross-tabs and Pearson´s chi square. The differences were considered 
statistically significant if p<0.0001.  
 
For comparison between Web sites, the one way ANOVA test was used. 
Results were expressed as mean and the increase was statistically analyzed. 
The differences were considered significant if p<0.05.  
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RESULTS 
4.1.  Data analysis 
 
4.1.1.  Discussion forum 
Within 32 months (15 January 2002 until 29 July 2004) there were 
2202 correspondence letters written to the experts. Most of the letters 
were written by those who had problems with endometriosis or 
symptoms of endometriosis. Only small numbers of men were writing 
for their wives, and some correspondents even wrote about other 
themes (outside endometriosis). Examples: letter number 130 on 15 
April 2002 was written by the husband of a woman with endometriosis, 
and letter number 199 on 20 May 2002, karoass@ asked about the Pap 
Smear Test.  
Because there was no standard for writing these letters, respondents 
were free to formulate their questions. The previous history might be a 
good clue to explain the problems and help the expert in answering the 
questions. The age of the correspondents was not always mentioned in 
the letters.  
 
Table 4.1.1.1. Activities of the references 
Name of the references Frequency Percent 
andreas.ebert@ 135 6.13 
buehlerfam@ 240 10.90 
edgardewitt@ 112 5.09 
gunther.goeretzlehner@ 199 9.04 
hans-rudolf.tinneberg@ 231 10.49 
joerg.keckstein@ 114 5.18 
lmettler@ 225 10.22 
martin.sillem@ 234 10.63 
michel.mueller@ 78 3.54 
regidor@ 145 6.58 
schindler@ 106 4.81 
schweppe@ 254 11.53 
thomas.roemer@ 129 5.86 
Total 2202 100 
 
4
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The most active correspondents were: 
Table 4.1.1.2. The most active respondents 
Email address Frequency of questions 
heike.kuemmel@  11 
baerbel.daub@                                       11 
yvonne.sagan@                                       10 
ralobe@                                                  9 
gwohlleber@                                          8 
mumie2001@                                         8 
ELubke@                                                7 
viviente@                                               6 
 
Based on the email address (where the correspondents live) 
demographics can be predicted (Table 4.1.1.3). 
 
 
The length of the questions was counted per characters by Excel for 
Windows XP. The result was calculated by SPPS for Windows version 
12. The mean letter had a total of 827 ± 596.71 characters. 
 
Table 4.1.1.3. Demographics of the correspondents 
Email address Country of origin* Frequency Percent 
.ag Antigua and Barbuda 1 0.05 
.at Austria 59 2.67 
.be Belgium 2 0.09 
.ch Switzerland 75 3.40 
.com International  430 19.52 
.de Germany 1535 69.70 
.edu Educational organization 1 0.05 
.es Spain 1 0.05 
.fr France 1 0.05 
.info Organization 2 0.09 
.it Italy 7 0.31 
.li Liechtenstein 2 0.09 
.lu Luxembourg 5 0.23 
.net Network system 62 2.81 
.nl Netherlands 3 0.14 
.no Norway 1 0.05 
.org International organization 4 0.18 
.pl Poland 1 0.05 
.pt Portugal 1 0.05 
.renault Company 4 0.18 
.ru Russian Federation 1 0.05 
.sg Singapore 1 0.05 
.uk United Kingdom 3 0.14 
Total  2202 100 
 * Source: http://www.iana.org/cctld/cctld-whois.htm 
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Table 4.1.1.4. Maximal and mean length of correspondence letters 
 N Maximum Mean SD Minimum 
Length of questions 2202 5285 827 596.71 19 
Length of answers 2202 2931 473 340.83 0 
 
Table 4.1.1.5. The most frequently chosen themes 
Themes Frequency Percent 
Alternative therapy 86 3.91 
Diagnostics 198 8.99 
Hormonal therapy 476 21.62 
Sterility 42 1.91 
Infertility 483 21.93 
Follow-up after operation 137 6.22 
Surgical therapy 224 10.17 
Pain therapy 71 3.22 
Lower abdominal pain 485 22.03 
Total 2202 100 
 
The most frequently asked questions were: 
 
Table 4.1.1.6. The most frequently asked questions based on the core questions  
Subgroups Frequency Percent 
Abdominal pain   
• Pain treatment 197 8.95 
• Bowel or bladder endometriosis and distant metastasis 53 2.41 
• Psychological effect 5 0.23 
Family planning   
• Chance of pregnancy 411 18.66 
• Pregnancy after hormonal therapy 64 2.91 
• Fertility after surgical therapy 18 0.82 
Hormonal therapy   
• Side effects 132 5.99 
• Tailoring of hormonal therapy 172 7.81 
Surgical therapy   
• Indication of surgical treatment 102 4.63 
• Tailoring of surgical treatment 80 3.63 
Follow-up   
• Follow-up after surgical therapy 158 7.18 
• Follow-up after medical treatment 29 1.32 
Alternative therapy 104 4.72 
Diagnostics 294 13.35 
Abnormal bleeding 28 1.27 
Endometriosis center 118 5.36 
Cost and insurance 29 1.32 
Recurrence 78 3.54 
Pathophysiology and pathogenesis  32 1.45 
Miscellaneous 98 4.45 
Total 2202 100 
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The chance of pregnancy in association with endometriosis was the 
most frequently asked question (19%). The patients were concerned 
about their fertility especially after the diagnosis had been made. 
Sample questions from patients of this group were:  
1. Is pregnancy made more difficult by endometriosis? 
2. How much time do I have to become pregnant? 
3. Do I still have any chance to become pregnant? 
 
Signs, symptoms, and how to diagnose endometriosis was an 
interesting topic. 13 % of the respondents wrote about their main 
complaints and asked the experts about the possibility that they had 
endometriosis. Most of them had not undergone laparoscopy for the 
diagnosis of endometriosis. Sample questions were: 
1. I have menstrual pain since my first period. I have read about 
endometriosis in the newspaper. I am afraid that I might have it. 
2. Half a year ago my menstrual bleeding became more extensive and 
I have more intensive menstrual pain although I take contraceptives. 
How could endometriosis be diagnosed or excluded? 
Figure 4.1.1.1. Distribution of the most frequently asked questions 
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3. Can endometriosis be diagnosed only by laparoscopy or is there 
any other method to diagnose it? 
 
Information about pain treatment was asked by 8.9% of the respondents. 
Respondents saw the pain as indescribable and frustrating. It is 
interesting to note the question: 
“What can I do? What happens when the pain does not go away? I do 
not know how I could begin my story.... 5 years ago endometriosis was 
diagnosed by laparoscopy, after that I had hormonal therapy for 6 
months. So far I have had 3 laparoscopies with hormonal treatment. 
The pain has not diminished but is even worsening, and I have more 
and more pain. It influences my daily life in spite of a shorter treatment 
interval”. 
 
Tailoring of the hormonal therapy was asked for by 7.8 % of the 
respondents. The main discussion in this topic concerned the best 
hormonal therapy, the dosage of the hormone, alternative therapy to 
hormones, schedule of therapy, and length of therapy. Samples of 
questions: 
1. I have been told to take mini-pills for 3 months. Is this right? 
2. I have been told to take Diane (contraceptive pill) for 3 months. 
Would you also advise me to take this medication? 
3. Which medication is better to treat endometriosis, Cerazette or 
Valette? 
 
7.2 % of the respondents inquired about the follow-up after surgical 
therapy. They wanted to know the next treatment after the operation, 
the time to begin hormonal therapy, the duration of hospitalization, 
second look operation, and rehabilitation. Samples of questions were: 
1. Is it possible to obtain rehabilitation after finishing all therapies for 
endometriosis?  
2. Once they told me to undergo hysterectomy and finally have 
another hormonal treatment.... now they told me to undergo 
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oophorectomy. I want to know what is going to happen to me after 
that. 
3. How long is the recovery time after hysterectomy?  
 
Side effects of medical treatment for endometriosis were asked by 6% 
of the respondents. Samples of questions were. 
1. I am going to have a series of injections to put me into the 
climacteric phase. What is the side effect of this medication? 
2. I have been given Yasmin (contraceptive pill) since the operation. 
Now I have no pain at all but I feel always sick, nauseous and 
hypoglycemic. Could it be the side effect of the hormone? 
3. Could a cyclic depression be related to endometriosis alone or also 
to the hormone treatment? 
 
5.4 % of the respondents considered endometriosis centers near their 
residence as an important information. They had their own 
gynecologist, but they felt it was better to have the entire treatment in 
an endometriosis center. They asked whether the experts could tell 
them a name or center in their neighborhood. 
 
It was apparent that the psychological factor played a big role in 
endometriosis. 5 respondents asked questions about this psychological 
factor. These questions were: 
1. I suffer from anxiety and emotional changes before my 
menstruation. Is this known also in endometriosis? 
2. Which psychological background plays a big role in endometriosis 
e.g. sexual abuse? 
3. Could dizziness be a result of endometriosis? 
4. Every month before my menstruation I have nasal bleeding for 4-5 
days. Interestingly it happened every month just before the 
menstruation. Could it be also endometriosis? My ENT doctor said 
it may only be a psychological factor. 
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5. May endometriosis cause a personality change on account of the 
extreme pain? 
 
4.1.2 Questionnaire 
 
All participants in this study had voluntarily filled out the questionnaire. 
They were recruited over a range of 12 months from 09 July 2003 until 
29 July 2004. From them, 10665 respondents were recruited who filled 
out the questionnaire. As shown in Figure 4.1.2.1, the questionnaire 
was divided into 2 groups of questions. The first part (questions 1 to 5) 
asked about the signs and symptoms of endometriosis. Question 6 
asked more about the medication, whether the respondents were taking 
oral contraceptives. It was obligatory to fill out this part completely in 
order to get the total point leading to the probability of endometriosis. 
In this case 10665 respondents completed questions 1 to 6.   
From the second part of the questionnaire (questions 7-12), information 
about the social impact of the pelvic pain as main symptom of 
endometriosis could be retrieved. It was not compulsory to complete 
the second part. Therefore only 45% of the questions 7-12 were 
completely answered.   
 
4.1.2.1. Distribution of answers 
 
Questions 1-6 
As shown in Table 4.1.2.1.1, the end result showed that the 
questionnaires were almost completely filled out by women who had 
dysmenorrhea (97%). The respondents experienced dysmenorrhea in 
different ways. 68% said they had dysmenorrhea in all menstrual 
bleedings, 20% said only occasionally, and 9% stated that painful 
menstrual bleeding was rare. The onset of pain together with the 
beginning of menstrual bleeding was recorded for 52% of symptomatic 
dysmenorrhea individuals. In addition, 48% of symptomatic 
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respondents claimed that they experienced dysmenorrhea days before 
the menstrual bleeding.  
74 % of the respondents found that the most painful time of the 
menstrual period was the onset of bleeding. Only 26% of the 
respondents experienced this extensive pain before the menstrual 
bleeding. Dysmenorrhea since the menarche was reported by 44% of 
all 10332 dysmenorrheal individuals. More than half of dysmenorrheal 
women (56%) stated that dysmenorrhea came after the menarche.  
 
Chronic pelvic pain was reported by 7616 respondents (71%). Only 
29% had no pelvic pain at all.  The distribution of chronic pelvic pain 
was varied, the intensity of pain ranging from extensive to mild. 
Extensive pelvic pain was reported by up to 43% of women with 
chronic pelvic pain. Dyspareunia was also recorded in 61% of all 
respondents. Within the dyspareunia group, 75% agreed that the pain 
depended on the coital position. Pain at the entrance of the vagina was 
reported by 13%, followed by 35% for pain in the pelvic area, and 52% 
for pain in the deep vagina. Interestingly, hematuria or hematochezia 
was claimed by 19% of the respondents. Infertility was an important 
subject by presenting the problem in 39% of all questionnaires. Among 
the total respondents only one fifth (21%) took contraceptive pills. 
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Table 4.1.2.1.1. Result of the questionnaires  
Questions Answers Frequency Percent Total 
1. Do you have painful periods? Always 7275 68.21  
 Occasionally 2157 20.23  
 Rarely 900 8.44  
 Never 333 3.12 10665 
1.1. If yes, when does the pain Days before the menstrual bleeding 4939 47.80  
begin in your period? With the menstrual bleeding 5393 52.20 10332 
1.2. If yes, when do you have the With the menstrual bleeding 7621 73.76  
most pain? Before the menstrual bleeding 2711 26.24 10332 
1.3. If yes, have you had this  At menarche 4693 45.42  
pain since the first time you had 
your period? After menarche 5639 54.58 10332 
     
2. Do you have lower abdominal 
pain monthly without having  Often 2591 24.29  
any menstrual period and you do 
not have any gastrointestinal Sometimes 5025 47.12  
problem? Never 3049 28.59 10665 
2.1 If yes, is this pain very deep  Extensive  3295 43.26  
and strong or only mild? Light 4321 56.74 7616 
     
3. Do you also have pain during Yes 6479 60.75  
intercourse? No 4186 39.25 10665 
3.1. If yes, does it depend on  Yes 4924 76.00  
the position at intercourse? No 1555 24.00 6479 
3.2. If yes, where is the center  Deep in the vagina 3370 52.01  
point of this pain? In the pelvic area  2250 34.73  
 At the entrance of the vagina 859 13.26 6479 
     
4. Do you also have bleeding 
with urination and bowel Yes 2047 19.19  
movement before or during 
menstruation? 
No 
8618 80.81 10665 
     
5. Do you have infertility Yes 4179 39.18  
Problems? No 6486 60.82 10665 
     
6. Are you currently taking  Yes 2250 21.10  
any contraceptives? No 8415 78.90 10665 
     
 
Questions 7-12 
4882 women gave information about alteration of their quality of life. 
The majority of respondents (51%) thought that their quality of life had 
been extremely reduced by the pain. While 12% had no alteration in 
their quality of life, 37% thought there was a moderate change in their 
quality of life. Extreme limitation of sexual activity was reported by 
36% (1754 respondents). Another 37% saw only mild problems during 
intercourse, and the rest (27%) saw no problem at all in sexual activity. 
Respondents generally (90%) appeared to be restricted in their daily 
activity by the menstrual pain. 60% of them even had extreme 
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restriction during their menstrual period. Only 10 % of them had no 
restriction at all in their physical activity. 51% of the respondents found 
that work performance was also decreased utmost by menstrual pain. 
Only 14% found no change in work performance and 35% agreed that 
there was only a modest effect on it. The restriction in work 
performance, obtained from the majority of respondents (64%), could 
be prolonged from one to three days in every menstrual bleeding. 
Impairment in the work place up to more than 3 days was reported by 
1133 respondents (24%). Only 594 women (12%) were working 
normally without limitation during the menstrual period.  
The total loss of working time in a year ranged from less than one day, 
two to ten days and more than ten days off work. 4815 respondents 
gave information about the time lost. Contrary to the impairment of 
work during menstrual pain, 58% of the women had taken only one day 
off in a calendar year of work during their menstrual cramp episode. 
Only 28% (1352 respondents) and 14% (653 respondents), respectively, 
had to stay at home more than 2 days because of their pain.  
 
Table 4.1.2.1.2. Result of the questionnaires  
Questions about Answers Frequency Percent Total 
Quality of life Extreme  2503 51.27  
 Moderate 1801 36.89  
 No effect 578 11.84 4882 
     
Sexual activity Extreme  1754 36.13  
 Moderate 1806 37.20  
 No effect 1295 26.67 4855 
     
Physical activity Extreme  2889 59.49  
 Moderate 1490 30.68  
 No effect 477 9.83 4856 
     
Productivity Extreme  2451 50.39  
 Moderate 1718 35.32  
 No effect 695 14.29 4864 
     
Days of impairment >3 days 1133 23.45  
 1-3 days 3105 64.26  
 0 day 594 12.29 4832 
     
Days of absence in a year >10 days 653 13.56  
 2-10 days 1352 28.08  
 0-1 day 2810 58.36 4815 
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10665 respondents recruited 
through internet Web site 
www.endometriose.de 
(09 July 2003-29 July 2004)
Social Effects: 
• Quality of life (4882) 
• Sexual activity (4855) 
• Physical function (4856) 
• Work performance (4864) 
• Days of impairment (4832) 
• Days of absence in a year (4815) 
Symptoms: 
• Dysmenorrhea primary / secondary 
• Chronic abdominal pain  
• Dysuria / tenesmus 
• Infertility 
• Dyspareunia 
• Hormonal contraception 
Scores: 0-3 
Endometriosis appears to be improbable: 
1.29% (138) 
Scores: 4-8 
Endometriosis appears less probable: 
12.55% (1339) 
Scores: 9-15 
A clarification appears to be present: 
58.91% (6282)  
Scores: 16-24 
A specific clarification of endometriosis 
must be urgently done: 27.25% (2906) 
Correlation (statistical test) 
Figure 4.1.2.1. Flow chart of scoring system from Endo-Test 
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  4.1.2.2.  Scoring system 
With the scoring system developed by Bühler, the entire questionnaire 
was evaluated. Based on symptoms and signs of endometriosis 
(questions number 1 to 6), the possibility of endometriosis was 
classified into 4 categories. Endometriosis appears to be improbable 
with a total of 0 – 3 points and less probable when the score reaches 4 – 
8. With scores up to 9 – 15, endometriosis appears to be probable. With 
scores up to 16 – 24, endometriosis should be highly suspected, and 
specific procedures leading to the diagnosis of endometriosis should be 
performed. 
 
The distribution of the total score can be seen in Table 4.1.2.2.1. The 
mean of total points is 12.89 ± 3.98. 59% of all respondents could be 
categorized as suspect of endometriosis (9–15 total points). 27% of the 
respondents could be categorized as apparently highly suspect of 
endometriosis (16-24 points). A specific clarification of endometriosis 
was strongly advised in this category. Only 2% was included in 
category one as improbability of endometriosis and 12% for a lesser 
probability of endometriosis.  
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Table 4.1.2.2.1. Distribution of total score for the prediction of endometriosis  
Total score Prediction Frequency Percent 
0 Improbable 41 0.38 
1 Improbable 30 0.28 
2 Improbable 35 0.33 
3 Improbable 32 0.30 
4 Less probable 41 0.38 
5 Less probable 79 0.75 
6 Less probable 197 1.85 
7 Less probable 458 4.29 
8 Less probable 564 5.29 
9 Appears to be probable 750 7.03 
10 Appears to be probable 861 8.07 
11 Appears to be probable 869 8.15 
12 Appears to be probable 941 8.82 
13 Appears to be probable 917 8.60 
14 Appears to be probable 986 9.25 
15 Appears to be probable 958 8.98 
16 Specific clarification need 823 7.72 
17 Specific clarification need 740 6.94 
18 Specific clarification need 539 5.05 
19 Specific clarification need 366 3.43 
20 Specific clarification need 232 2.18 
21 Specific clarification need 116 1.09 
22 Specific clarification need 58 0.54 
23 Specific clarification need 23 0.22 
24 Specific clarification need 9 0.08 
 Total 10665 100 
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Figure 4.1.2.2.1. Distribution of total score 
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4.1.3. Web site comparison 
 
The first 20 results from both search engines (Yahoo and AltaVista) are 
similar. The complete address was shown in Table 11.10 - Appendix. 
The overall scores for the three scoring scales were average. The mean 
score for the overall score was 14. 
 
Web site ownership information  
The source of the information is considered a marker of quality and 
enhances the credibility of the Web site. Regarding the Web site 
ownership information, 80% of Web sites clearly indicated information 
about ownership and affiliation. However, only 55% showed copyright 
information of specific content. Moreover, only 45% of Web sites 
asked about registration and password protection. Information about 
payment subscriptions, document delivery and viewing was provided 
only by 45% (9) of all 20 Web sites. The complete distributions are 
shown in Table 11.10 - Appendix. 
 
Editorial content 
Regarding the quality of the Web site content, 65% of Web sites listed 
all staff members and individuals responsible for content quality. 
However, only 35% of Web sites reviewed the content for quality, 
including originality, accuracy, and reliability by either peer review or 
editorial boards. As for the timeliness of the Web contents, only 15% 
posted the date of the content publications and revisions. The sources 
of specific contents were noticed only in 30% of the Web sites.  
 
Navigation of Web contents 
Regarding the navigational function, 60% of Web sites provided the 
search engine for their own Web contents. 50% of Web sites offered 
customer service information, which included the so-called internet 
consultation. But only 40% of Web sites featured frequently asked 
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questions. PDF files and software download navigation was integrated 
in 60% of the Web site. Most Web sites were easy to navigate through 
functional internal-external links and allowed viewers to return to a 
previously browsed Web page. 
 
There were 8 Web sites (40%) which received the HON certificate. The 
HON logo was placed on the Web site. Only 2 Web sites (10%) 
belonged to the government. 6 Web sites (30%) were managed by 
foundations, e.g. Europäisches Endometriose Informations-Centrum 
(EEIC), Endometriosis Associations, Endometriosis Research Center, 
etc. And 6 Web sites (30%) were sponsored by a private company, e.g. 
profit internet provider, pharmaceutical company.  
 
4.2. Statistical analysis  
 
4.2.1.  Questionnaire 
From a total of 18 questions (12 main questions, and 6 sub-questions), 
153 correlations could be combined. The pattern of total scores can be 
found in Table 4.1.2.2.1 and Figure 4.1.2.2.1. 
 
Dysmenorrhea  
Respondents with continuous dysmenorrhea reported more frequent 
chronic pelvic pain (p<0.0001%) than respondents with less 
dysmenorrhea. There was a significant increase in the intensity of 
pelvic pain with increased frequency of dysmenorrhea (p<0.0001). 
Another result indicated that women with continual dysmenorrhea were 
more likely to have dyspareunia, more likely to have rectal or urinary 
bleeding, more likely to have infertility but did not take contraceptive 
pills (p<0.0001).  The summary of the correlation between 
dysmenorrhea with other endometriosis-associated symptoms is shown 
in Table 4.2.1.1. 
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As expected, there was a significant correlation between dysmenorrhea 
and quality of life. 32% of the respondents without dysmenorrhea had 
no change in their quality of life, whereas in severe dysmenorrhea 
groups an extreme change in the quality of life was reported by 60% of 
the respondents. Respondents with more frequent dysmenorrhea had a 
significant likelihood of staying in bed or missing work on more than 
10 days per year (p<0.0001). Table 4.2.1.3 shows the correlation 
between dysmenorrhea and social impact.  
 
Dyspareunia  
Regarding dyspareunia there was a tendency that respondents with 
more frequent dysmenorrhea were more likely to have dyspareunia 
(p<0.0001). As expected, dyspareunic women had difficulties in their 
sexual life. 48% of the respondents with dyspareunia even had 
extremely limited sexual activity (p<0.0001). But dyspareunia alone 
had no significant relationship with infertility (p=0.204). A summary of 
the correlation between each parameter is shown in Table 4.2.1.2. 
 
Social impact 
The correlation between social impacts with endometriosis-associated 
symptoms was tested by the chi square test.  
 
Quality of life in respondents with more frequent dysmenorrhea was 
extremely reduced. 60% of respondents reported an extremely reduced 
quality of life and having dysmenorrhea all the time. Dysmenorrhea in 
this group was characterized by the onset of pain days before bleeding. 
Dysmenorrhea since menarche (p=0.08) and the most painful day 
during the menstrual bleeding (p=0.003) were not significantly related 
with the quality of life. Respondents with extreme changes in the 
quality of life more often had extensive chronic pelvic pain, 
dyspareunia, infertility, hematuria, and hematochezia (p<0.0001). 
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Extreme limitation of sexual activity was reported by 1754 respondents. 
Sexual activity was also extremely limited by always having 
dysmenorrhea, frequent and extensive chronic pelvic pain, dyspareunia, 
infertility, hematuria and hematochezia.  
 
Productivity was also restricted by endometriosis-associated symptoms, 
and these changes were reported by 4864 respondents (46%). 
Respondents with more frequent dysmenorrhea tended to have a higher 
restriction of productivity (p<0.0001). Chronic pelvic pain influenced 
productivity also significantly (p<0.0001). 
 
The most important quantitative indicators for the social impact of 
endometriosis were reduced-activity days, and time lost from work. 
Almost half of the respondents (45%) gave this information. Days of 
impairment by endometriosis-associated pain ranged between 0, 1-3 
and more than 3 days, and time lost from work was indicated by days 
of absence in a year ranging from 0-1 day, 2-10 days, and more than 
ten days. Respondents who had more than three reduced-activity days 
during their menstrual pain had a tendency to have dyspareunia, more 
frequently dysmenorrhea, more often chronic pelvic pain, hematuria or 
hematochezia, and the use of oral contraceptives (p<0.0001). 
Dysmenorrhea in this group was characterized by onset some days 
before the bleeding, and the maximum painful time being before the 
time of bleeding. Chronic pelvic pain in respondents with more than 
three reduced-activity days was described as extreme pain.   
 
14 % of 4815 respondents who gave information about time lost from 
work stated that they were absent from work more than 10 days a year. 
These respondents reported more frequent dysmenorrhea, more 
extensive pelvic pain, a tendency to have dyspareunia, hematuria or 
hematochezia (p<0.0001), but not infertility (p=0.007) and use of oral 
contraceptives (p=0.029). Indeed, dysmenorrhea was characterized 
only with its onset days before the time of bleeding (p<0.0001). 
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Total score 
The total score could be related by using the ANOVA test with social 
impact. A significant correlation could be also found between 
categorization of the sum score and the social data.  
 
In the quality of life group there was a significant reduction of the 
quality of life with a higher probability of endometriosis (p<0.0001). 
Twelve percent of the respondents recalled no change in the quality of 
life, and had a mean score of 11.37 ± 3.22. Increased total scores were 
found significant for respondents with lower quality of life. 2503 
respondents with extremely poor quality of life had a mean score of 
14.43 ± 3.54.  
 
This was also to be expected for the sexual activity group. Reduction of 
sexual activity was significantly correlated with intensified probability 
of endometriosis (p<0.0001). Women with no change of their sexual 
life had a mean score of 11.12 ± 2.96, whereas women with a moderate 
disturbance had a mean score of 13.60 ± 3.23 and with severe 
disturbance a mean score of 15.18 ± 3.35. The mean scores of these 
respondents increased significantly (p<0.0001) with the level of 
disturbance in their sexual activities. 
 
Respondents with a higher probability of endometriosis score had also 
more disturbances in their physical activity, and this correlation was 
statistically significant (p<0.0001). 4856 respondents reported 
reduction of physical activity during menstrual pain which ranged 
between ‘no effect’, ‘moderate’, and ‘extreme’. The mean score of 
respondents with moderate limitation was 12.89 ± 3.38. A significant 
score change was calculated for women with extreme physical 
limitation (mean: 14.19 ± 3.49). 
 
 
Endometriosis-associated Pain, Social Impact, and Information through Internet Survey 
 
 
47
By using the ANOVA test productivity was correlated with total score. 
Extreme limited productivity was reported by respondents with the 
highest probability of endometriosis (p<0.0001). Moderate restrictions 
had mean scores of 13.29 ± 3.40, while extreme restrictions reached 
mean scores of 14.19 ± 3.55. 
 
No respondents (0%) with the lowest probability of endometriosis 
(score 0–3) had given information about disability in their work for 
more than 3 days during their menstrual pain (Table 11.9 – Appendix). 
And 544 (37%) from a total of 4832 respondents with maximal 
endometriosis score had reported that they were disabled in work for 
more than 3 days because of their menstrual pain. This correlation was 
statistically significant (p<0.0001). Analysis showed that respondents 
who had work limitations for more than 3 days during their menstrual 
cycle had a significantly higher score (p<0.0001).  
 
Comparison between the yearly days of absence with the total of points 
(Table 4.2.1.5) showed that the total scores of respondents who had 
more than 10 days of absence from work in a calendar year were 
significantly higher than those of respondents with less than 10 days of 
absence (p<0.0001). 
 
None of the respondents with an endometriosis score between 0–3 were 
disabled for more than 2 days. The proportion of respondents with 
overall lost working time of more than 10 days per year significantly 
increased in groups with a higher endometriosis score (p<0.0001). 296 
respondents had reported lost working time for more than 10 days and 
had the highest probability of having endometriosis.   
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Table 4.2.1.4. Mean of total score from social impact questions 
 N Mean SD 
Quality of life    
No effect 578 11.37 3.22 
Moderate 1801 12.90 3.31 
Extreme 2503 14.43 3.54 
Total 4882 13.50 3.58 
    
Sexual activity    
No effect 1295 11.12 2.96 
Moderate 1806 13.60 3.23 
Extreme 1754 15.18 3.35 
Total 4855 13.51 3.58 
    
Physical activity    
No effect 477 11.23 3.37 
Moderate 1490 12.89 3.38 
Extreme 2889 14.19 3.49 
Total 4856 13.50 3.57 
    
Productivity    
No effect 695 11.58 3.31 
Moderate 1718 13.29 3.40 
Extreme 2451 14.19 3.55 
Total 4864 13.50 3.58 
    
Impairment days    
0 day 594 11.71 3.46 
1-3 days 3105 13.25 3.39 
>3 days 1133 15.16 3.49 
Total 4832 13.51 3.58 
    
Absence days in a year    
0-1 day 2810 12.86 3.43 
2-10 days 1352 14.18 3.48 
>10 days 653 14.96 3.70 
Total 4815 13.51 3.58 
 
 
Table 4.2.1.5. Correlation of probability of endometriosis with absence days in a year 
Category of sum score (probably of endometriosis) Absence days (n=4815) 0 – 3 4 – 8 9 – 15 16 – 24 
0 – 1 day 9 (0.32%) 265 (9.43%) 1883 (67.01%) 653 (23.24%) 
2 – 10 days 0 (0%) 71 (5.25%) 777 (57.47%) 504 (37.28%) 
> 10 days 0 (0%) 30 (4.59%) 327 (50.08%) 296 (45.33%) 
Pearson’s chi-square test:   p<0.0001 
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4.2.2. Web site comparison 
 
Most of the Web sites (60%) were classified only as average. Only 
30% of them were categorized as good Web sites. The mean score for 
the 20 endometriosis Web sites was 14.  
 
Web sites which place a HON Certificate on their sites were compared 
with Web sites without HON certificate. Web sites with a HON 
Certificate had higher scores (11.83 vs. 18.13, p<0.05) than Web sites 
without the HON Logo.
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DISCUSSION 
Internet Consultation 
 
The proportion of publications about patients searching for medical information in the 
internet is limited. Few data are available to date on the subject of internet use of study 
for such purpose, and the study available that sheds some light on this question is a 
European study by Coulter and Magee132. Jeannot133 has also reported about patients’ 
use of the internet for health care in Switzerland. It showed that only 10 % of 
respondents used the internet to find medical information133. Another study was 
performed in the USA by Diaz134 and showed that almost 53.5% of patients visiting 5 
general internists used the internet for medical information. Those using the internet for 
medical information were more educated134. Hufken181 had tried to find out the internet 
use for health information among the German population. He found through computer-
assisted telephone interviews that approximately 50% of 2026 respondents used the 
internet to look for advice or information about health or health care. 
 
Over a period of 16 months, the homepage www.endometriose.de recruited 237,159 
visitors. The discussion forum, as part of www.endometriose.de, was attended by 2202 
respondents. The Endo-Test was filled out by 10,665 respondents. We considered the 
report of Hufken181 that round 50% of German patients are using the internet for 
medical information and counted our respondents to predict how many people dealt 
with endometriosis. We reached a number of 474,318, a very large number of patients 
with endometriotic problems. Based on statistical data in 2003 from the Statistisches 
Bundesamt Deutschland182, there were about 17,417,000 women living in Germany, 
aged 15 to 45 years. With an endometriosis prevalence of 2-10% among the general 
population, about 350,000 to 1,741,000 women in reproductive age are probable to have 
endometriosis. 
 
Limited details have been reported about the information needs of women with 
endometriosis, particularly when this information was collected through an internet site. 
The importance of using the internet as a source of medical information has become 
5
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increasingly popular as more patients “go online”. According to a survey in the United 
States, 93 million adults (80% of adult internet users) have used the World Wide Web 
to obtain health or medical information135. By 2005, an estimated 88.5 million adults 
will use the internet to search for health information and / or health-related products and 
to communicate with providers136. Access to a large amount of medical information is 
available through an estimated 20,000 to 100,000 health-related Web sites137. 
 
The finding of this study showed that as many as 411 (19%) of the participants focused 
their endometriotic problem on the chance of pregnancy. Half of them were trying to 
become pregnant or had infertility problems and had already undergone IVF (in vitro 
fertilization) therapy. Some of them were frustrated because their family planning could 
not be fulfilled. Here, support groups play an important role in educating the patients, in 
changing perception about endometriosis, and as media for counseling and the sharing 
of experience.  
 
Secondly, how to diagnose endometriosis was a great problem for the patients (13%). 
The main question from this group was “Do I have endometriosis?” and this question 
would be followed by “is laparoscopy or laparotomy the only possibility for the 
diagnosis of endometriosis?” At present there are no simple noninvasive diagnostic tests 
and endometriosis still remains an enigmatic condition31. Although direct assessment of 
endometriotic foci at laparoscopy may be viewed as a “gold standard” for identifying 
endometriosis, the correlation of laparoscopic observation with histological findings is 
often poor.  
 
Thirdly, treatment of pain was an important subject in the discussion forum. Most of the 
respondents were frustrated by untreatable pain. Taking pain killers is not a solution for 
these patients. Correct indication for surgery, tailoring of the surgical treatment 
according to the patient’s needs, would be the next question of the entire treatment. 
Many treatment options are nowadays available, such as hormonal treatment with 
medroxyprogesterone acetate138, oral contraceptives100, goserelin plus anastrozole139, 
danazol140, GnRH agonist therapy141, uterine nerve ablation by laparoscopy142, ablative 
laparoscopic surgery143, and social support including endometriosis groups. Most of the 
medical treatments have been demonstrated to achieve pain relief in more than 75%96. 
However, treatment of this condition is sometimes unrewarding owing to a lack of 
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effective interventions, and more radical surgery such as hysterectomy often becomes 
the final option142. It is the duty of medical staff to discuss the therapy plan with the 
patients. 
 
Although pelvic pain, dysmenorrhea, dyspareunia, and infertility are considered typical 
symptoms of endometriosis, our respondents addressed other multiple and varied 
questions. Another finding documented by Denny et al.118 showed that delay in the 
diagnosis of endometriosis, pain, dyspareunia, and treatment were the identified key 
areas of discussions. Severe pain was often described as intense or overwhelming118. 
Cox144 reported that the lack of support, the struggle, the losses involved in living with 
endometriosis, and trivialization of symptoms were the main findings from 61 women 
facing laparoscopy for endometriosis.  
 
The findings of this study addressed a gap in the research literature about the 
information needs of women with endometriosis. Most of the mentioned literature may 
be limited by the number of respondents. They were asked passively, either by personal 
interview or by telephone. This study had brought a large number of respondents 
addressing the questions actively, freely and without limitation.  
 
The study had several limitations. Multiple questions were addressed at the same time 
and most of all contained different topics. We summarized only the core of the letters. 
Therefore the summary did not reflect the consultation letters completely. Other points 
of view from these letters are not less important.  
 
Future directions of research studies should be undertaken, particularly in the area of 
discussion forums for endometriosis. Diagnosis of endometriosis among the 
respondents should be collected, and the form of the question should be standardized.  
 
Internet questionnaires 
 
The primary outcomes studied were the six domains of endometriosis – chronic pelvic 
pain, dysmenorrhea, dyspareunia, hematochezia or hematuria, infertility, use of oral 
contraceptives and the relationship with six social impacts – quality of life, sexual 
activity, physical activity, productivity, working activity, and lost of working time. A 
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multidimensional scale was developed by Biberoglu and Behrman140 and has been 
widely used in many interventional studies. In this scale, symptoms of dysmenorrhea, 
dyspareunia, pelvic pain were scored by the patients and the physical findings of pelvic 
tenderness and indurations were scored by the physician. The sums of these variables 
comprised the Total Pelvic Symptom Score (TPSS)140. From an estimated 5 to 7 million 
women with endometriosis, 2 to 5 million experience pain, 200,000 to 800,000 
infertility and 100,000 to 200,000 endometriomas1. Infertility and pain cause a serious 
disruption of life as well as psychological sequels. In our study, questions were 
formulated to be easily understandable and without bringing any confusion. Therefore 
the questions were answered by simple options. Scoring was performed according to the 
study of Dr. Bühler et al. (unpublished study). Up to now no available questionnaire can 
be used to diagnose endometriosis. Another English-based internet questionnaire with 
44 points of questions was placed by the Endometriosis All Party Parliamentary Group 
(EAPPG) with support from the National Endometriosis Society UK in 
www.endometriosis.appg.org/survey.htm. In this questionnaire the diagnosis of 
endometriosis was asked for in detail, including the time of diagnosis, how the 
diagnosis of endometriosis was made, and also questions about misdiagnosis. In our 
questionnaire, the data of physical findings by the physician and information about the 
diagnosis of endometriosis were not collected.  
 
A number of studies in the past few years have examined the association between 
chronic pelvic pain and quality of life. Some instruments with established disease-
specific questionnaires have been developed to measure the health/quality of life of 
women with endometriosis145,146,147,148. But these health or quality of life questionnaires 
were complicated and not applicable in the internet questionnaire. Therefore the social 
impact of the respondents’ symptoms was classified as severe, moderate or absent.  
 
Dysmenorrhea was reported by 97% of the respondents at different levels of frequency. 
Chronic pelvic pain was also reported by 71% of the respondents. Collectively, 
dysmenorrhea and chronic pelvic pain were reported by 7458 respondents (70%). Pain 
may occur in women without pelvic pathology, as even normal menstruation releases 
prostaglandins that contribute to the sensation of pain149. Dysmenorrhea is reported in 
up to 50% of women, most of whom do not have pelvic pathology150. In the literature, 
the prevalence of endometriosis among dysmenorrheal women was up to 76% and up to 
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45% among women with chronic pelvic pain. Dysmenorrhea itself is a common 
condition that occurs in 52%151,152, 72%153,154,155 of women, respectively. Another study 
by Weissman156 found that 77% of 404 women without endometriosis, pelvic 
inflammatory disease or uterine fibroids (female students and graduates of the College 
of Nursing) had dysmenorrhea of different severity. A summary of the characteristics of 
patients with endometriosis from different publications is shown in Table 11.2 - 
Appendix.  
 
Weissman156 found that oral contraception was not significantly associated with less 
severe dysmenorrhea. Our findings showed that less frequent dysmenorrhea was 
significantly associated with taking oral contraceptives (p<0.0001). Previous studies 
have found that dysmenorrhea causes frequent absence from work in 5-14% of women 
and absence from school in 14-46% of adolescents. Weissman156 reported also that 2% 
of the respondents had dysmenorrhea that was severe enough to warrant staying home 
in bed. In our study, always having dysmenorrhea during the menstrual bleeding caused 
a more frequent absence from work (more than 10 days per year) in 615 participants 
(p<0.0001).  
 
A public health study showed that active-duty patients required on average 15 days of 
sick leave per hospital admission related to endometriosis. For this reason the US Army 
had a policy to disqualify female recruits with a history of endometriosis157.  
Another finding of Boling158 revealed that the estimated loss of duty time was 21,746 
days in the United States Army. Our findings showed that 296 (20%) respondents with 
the highest probability of having endometriosis reported disability for more than 10 
days (p<0.0001).    
Table 5.1. Correlation of probability of endometriosis and days of disability 
Category of sum score  Disability days (n=4815) 
(probability of endometriosis) 0 – 1 day 2 – 10 days >10 days 
0 – 3  9 (100%) 0 (0%)  0 (0%) 
4 – 8   265 (72.40%) 71 (19.40%) 30 (8.20%) 
9 – 15  1883 (63.04%) 777 (26.01%) 327 (10.95%) 
16 – 24 653 (44.94%) 504 (34.69%) 296 (20.37%) 
Pearson’s chi square test:    p<0.0001 
 
The lack of diagnosis of endometriosis limited our study. Although 
www.endometriose.de presents mostly information about endometriosis, the viewers are 
not restricted to women with endometriosis. The Web page is opened for anyone who 
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has internet access. Therefore registration and password protection are needed. Future 
study should be aimed at finding the correlation between the questionnaire and the 
diagnosis of endometriosis. Developing an accurate scoring system for the questionnaire 
should be also examined in the future study.  
 
Endometriosis Web sites  
 
There are thousands of Web sites on endometriosis, and patients or women are unlikely 
to review pages and pages of a search to locate the best sites, even if they had the 
knowledge and skill to evaluate their quality. In evaluating health Web sites, the source 
of the information is considered a marker of quality, but the source does not guarantee 
that the information is relevant and comprehensive. Professional organizations, 
universities, and government agencies are considered reliable and credible sources of 
health information in the Web. Individual health care providers and organized groups of 
health care providers are clearly sources of authoritative medical information. And 
organizations such as consumer advocacy groups, voluntary health-related organizations, 
public health communities, and patient support organizations can also be considered 
credible sources of information relating to their area of expertise. Similarly, hospitals, 
large group practices and other entities that bring together medically knowledgeable 
professionals have aggregate credibility. And university medical schools may have the 
highest degree of medical credibility since they are expected to represent collections of 
specialized physicians who are the spearheads of medical knowledge. 45% of these 
Web sites have been developed by reputable sources such as foundations, government-
affiliated organizations and health organizations. Regarding the quality of editorial 
content, most sites lacked descriptions of the editorial process (35%), the source of 
specific content (30%), and dates on posting (15%). 
 
Due to the lack of a peer-review process, such as that used for medical journals, the 
validity of information on these Web sites is sometimes questionable. This evidence 
was in the form of research studies cited from medical publications, a list of references, 
or supporting statements from reputable organization such as the American Academy of 
Family Physicians and the National Endometriosis Society United Kingdom. The 
content of the information presented on a health Web site should be accurate and 
supported by evidence such as clinical trials. 16 (80 %) of the Web sites provided 
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evidence or expert opinion to support the information they presented in their homepage. 
Many included links to additional resources. www.endozone.org provided a direct link 
to additional information about newest clinical trials. Other sites included general 
resources to supplement the information of the page, such as links to the 
www.obgyn.net. 
 
Most Web sites provided information about Web site ownership (80%), copyright and 
sponsorship of any specific content (55%). But most Web sites failed to provide 
information about restriction on access to content, including registration, password 
protection (45%), and payment (45%). These findings are consistent with a study by 
Huang159. Although most Web sites were easy to navigate, features of site map, FAQ 
(frequently asked questions) are seldom found.  
 
Another strategy to search health Web sites is to find the internet quality of control seals, 
for example, the HON seal of approval. In our study only 40% of the Web sites had this 
HON seal of approval. As the use of the internet continues to gain in popularity, more 
people are turning to Web sites for health information. However, there are still Web 
sites that promote particular products, and might give misleading information. In the 
latest report about the quality of fertility clinic Web sites, Huang159 concluded that most 
of them did not routinely meet the AMA (American Medical Association) guidelines for 
Web sites. Our study showed that Web sites with the HON certificate had a significantly 
higher score than Web sites without the HON certificate.   
 
There were 3 Web sites using prestigious sound-alike names to promote a product or 
service (Lupron Depot®, Progestelle and Endo-Fem® with PMS Plus®). Additionally, 
none of the sites evaluated here suggested any “amazing result”, “earthshaking 
breakthroughs”, or “miracle cures” for endometriosis. 
 
www.endometriose.de met 16 criterions from a total of 26 points in this study. Some 
lacks of performance could be improved. Restriction of access by requesting password 
or registration could protect the information from computer freaks, Web hijackers or 
illegal copiers. Information about description of the editorial process, review process, 
and time of update or posting can increase credibility and competence. 
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CONCLUSION 
Endometriosis is a chronic disease and one of the most common gynecologic conditions 
that have a physical and psychosocial impact on women. It was reported for the first 
time by Shroen in 1690 as “ulcer in peritoneal cavities”. Prior to Sampson’s metastatic 
theory in 1921, attention of research was focused on the molecular pathogenesis of 
endometriosis. Better understanding of the pathogenesis of the disease and precise 
molecular targets promise new effective and efficient treatments with minimal side 
effects. The efficacy of the latest treatments is still argued and controversial. Teaching 
patients about endometriosis and its treatment, providing written information, and 
sharing educational electronic resources may take place through the internet.  It has well 
been characterized as disease without lobby since it lacks public awareness even though 
being one of the most frequent benign diseases in women. In order to provide adequate 
and easily accessible information for patients as well as health workers, an Internet Web 
site was created, www.endometriose.de that enables interested people to inform 
themselves and counsel free of charge on their endometriosis-associated problems.  
 
The chance of pregnancy (19%) under diagnosis of endometriosis was the most 
frequently asked question. This core of question could be retrieved from totally 2202 
internet consultations, which were sent between January 2002 and July 2004. Other 
main topics addressed were: diagnostic procedure, treatment of endometriosis 
associated pain, and hormonal therapies. Side effects of the medical treatment, surgical 
therapies and alternative therapies occurred less frequently as well as question 
considering recurrence and disease follow up. The distribution of dysmenorrhea in our 
population was 97% and chronic pelvic pain 71% as well. Dyspareunia alone has no 
direct cause of infertility (p>0.0001). The severity of the endometriosis-associated 
symptoms increases significantly with the reduction of social impact in terms of quality 
of life, sexual activities, physical activities, productivities, impairment days and annual 
absent days (p<0.0001). 6.1% of our respondents have the most endometriosis-
associated symptoms and need more than 10 days absence from work per year.  
 
6
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As the use of the internet continues to gain in popularity, more people are turning to 
Web sites for health information. Persons using the Internet for searching health 
information are better informed after reading, interactive tasks, and virtual consultation. 
However, there are still some Web sites, which deliver inaccurate information, 
promotion and marketing that can misguide the whole information. With major search 
engine, more than 900.000 Web sites about endometriosis were found. But only 30% of 
them were categorized as good Web sites. 40% of these Web sites had a HON seal of 
approval. Our study showed that Web sites with the HON certificate had a significantly 
higher score than Web sites without the HON certificate. Therefore, a HON certificate 
could help the visitors to evaluate the quality of the Web sites. Health provider should 
be prepared to answer questions and offer suggestions for Internet based health 
resources. 
 
Data collected from the www.endometriose.de interactive platform enable us to inform 
health insurance companies, politicians, and doctors about the needs of endometriosis 
patients. If a computer is online and available in the health setting for the education of 
patients, Web sites can be bookmarked for use by patients while waiting for their 
appointment with the doctor.  
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SUMMARY 
Women with chronic pelvic pain, infertility and dysmenorrhea try to search for help 
about their problems. Although the most important symptoms of endometriosis are 
chronic pelvic pain, infertility, dysmenorrhea and dyspareunia, laparoscopic assessment 
in combination with histological examination remains the gold standard for the 
definitive diagnosis of endometriosis. The lack of information about these problems is 
accompanied by both uncertainty and emotional distress. Since the information should 
be easily accessible, an internet platform was developed by the EEIC allowing extensive 
information on endometriosis and also providing a so-called “Endo-Test” as well as an 
open discussion forum. The needed information of endometriosis was studied through 
discussion forum and the endometriosis-associated symptoms and social impacts were 
collected through an internet questionnaire. The data were collected in an interval of 
time. Discussion forum were limited from January 2002 until July 2004. 2202 internet 
consultations were identified and analyzed. 10665 questionnaires were filled out from 
July 2003 to July 2004. 20 internet Web sites about endometriosis were evaluated based 
on criterion, which were published by Huang et al.  
Women with pelvic pain, dysmenorrhea, infertility, and dyspareunia need more 
information about fertility, diagnosis of endometriosis, pain treatment, followed by 
tailoring of hormonal therapy, and follow-up after surgical therapy.  
71% of our studied population (7616 of 10665 respondents) had chronic pelvic pain and 
the prevalence of chronic pelvic pain among our total visitor was 3.2% (7616 of 
241,393). Extensive chronic pelvic pain was reported by up to 43% of the respondent.  
The distribution of dysmenorrhea was 97% (10332 of 10665 respondents) and the 
prevalence of dysmenorrhea among studied population (10332 of 241,393) was 4.3%. 
The distribution of dyspareunia was 61% (6479 of 10665 respondents) and the 
prevalence of dyspareunia among studied population (6479 of 241,393) was 2.7%. 
The distribution of infertility was 39% (4179 of 10665 respondents) and the prevalence 
of infertility among our visitors (4179 of 241,393) was 1.7%.  
Quality of life was significantly reduced by a more frequent dysmenorrhea and higher 
endometriosis score (p<0.0001). The majority of respondents (51%) reported about 
extremely reduced quality of life.  
7
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Productivity was significantly reduced with a higher endometriosis score (p<0.0001). 
Up to 50% from the respondents had an extreme limited productivity.  
More than 10 disability-days from work per year were reported by 296 (6.1%) 
respondents with the highest endometriosis score.  
27.2% (2906 respondents) having the highest endometriosis score could be suspected to 
have endometriosis. Further study should be aimed at finding the correlation between 
the questionnaires and the diagnosis of endometriosis.  
Information about definition, pathogenesis, symptoms, diagnosis, treatment, 
rehabilitation of endometriosis and also supportive therapy inclusive self-help group, 
chat room, online consultation can be found on the internet. The source of information 
is considered a marker of quality, but the source does not guarantee that the information 
is relevant and comprehensive.  
Web sites such as familydoctor.org, www.endocenter.org, www.endozone.org, 
www.endometriose.de meet the standard criteria. The HON certificate could help the 
visitors to evaluate the quality of the Web sites. Professional organizations, universities, 
and government agencies are considered reliable and credible sources of health 
information on the Web. Standardization and certification could help the patients or 
internet surfers to find and evaluate the Web sites by themselves. 
 
Keywords: endometriosis, social impacts, internet consultation, Web sites. 
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ABBREVIATIONS 
AFS: American Fertility Society 
AMA: American Medical Association 
ANOVA: Analysis Of Variance 
CA-125: Cancer Antigen-125 
CSV: Comma-Separated Values 
EAPPG: Endometriosis All Party Parliamentary Group  
EEIC: Europäisches Endometriose Informations-Centrum 
ENT: Ear-Nose-Throat 
FSH: Follicle Stimulating Hormone 
GnRH: Gonadotropin-Releasing Hormone 
HITI: Health Information Technology Institute 
HON: Health on the Net 
HTML: Hypertext Markup Language 
IVF: In Vitro Fertilization 
JLU Giessen: Justus Liebig Universität Giessen 
LH: Luteinizing Hormone 
MPA: Medroxy-Progesterone Acetate 
MRI: Magnetic Resonance Imaging 
MSN: Microsoft Network 
NK cells: Natural Kill cells 
ppt: parts per trillion 
SD: Standard Deviation 
SPSS: Statistical Package for the Social Sciences 
TCDD: 2,3,7,8-TetraChloroDibenzo-p-Dioxin 
TCM: Traditional Chinese Medicine 
TNF-α inhibitor: Tumor Necrosis Factor - α inhibitor 
TPSS: Total Pelvic Symptom Score 
TXT: text 
URAC’s: Utilization Review Accreditation Commission 
URL: Uniform Resource Locator 
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Table 11.1. Prevalence of endometriosis in different ethnic groups according to symptoms or operations 
Ethnic groups Symptoms/operations African indigenous (%) African-American (%) Caucasian (%) General (%) 
Asymptomatic - - - 2-22[34,35,72] 
Tubal ligation - - 6[171] 4.1[34] 
Pelvic pain - - 15[171] 
45[72] 
24[34] 
Infertility  1.8[161] 
1.4[162] 
2[163] 
2.6[166] 4.7[166] 
13-33[172] 
21[171] 
30[72] 
20[34] 
20-30[72,173,174] 
Infertility/pain/abnormal 
bleeding/benign gynecology 
- 65[167] 
23[168] 
15[167] 
35[72] 
- 
Hysterectomy - 9[169] 20[169] 
25[171] 
- 
Gynecological surgery 
excluding laparoscopy 
0.2[164] 
0.4[165] 
6.9[170] 7.7[170] - 
Dysmenorrhoea - - - 40-60[72,173,174] 
* Numbers in brackets correspond to references 
Figure 11.1. Cullen’s diagram illustrating the distribution of adenomyomata 
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Figure 11.3. Dioxins and related congeners 
Figure 11.2. Immune alterations and endometriosis (Adapted from Berkkanoglu and Arici)47 
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Figure 11.4. Peritoneal 
implant of 
endometriosis at 
bladder peritoneal 
surface 
Figure 11.5. Endometrioma 
appearances (4 cm) in 
laparoscopic assessment  
(31-year-old patient with 
recurrent endometriotic cyst 
and abdominal pain) 
Figure 11.6. Deep 
infiltrating 
endometriosis 
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Table 11.4. Surgical principles in the treatment of endometriosis103 
Knowledge of disease and treatment modalities 
Experienced surgeon 
Adequate facilities, personnel, and equipment 
Appropriate patient selection 
Informed consent 
Proper patient position 
Careful pelvic evaluation 
Maximum exposure 
Use of magnification 
Minimum tissue trauma 
Excellent haemostasis 
Removal of all diseased tissue 
Avoidance of foreign body material 
Confirmation through pathology 
* Adapted from Adamson103  
 
Table 11.3. Markers for endometriosis87 
Tumor markers and polypeptides 
a. CA-125, CA-19-9 
b. SICAM-1 (soluble forms of the intercellular adhesion molecule-1) 
c. Glycodelin-A (PP 14) 
 
Immunological markers 
a.  Cytokines: IL-6, TNF 
b. Autoantibodies 
1. Antiendometrial 
2. Autoantibodies to markers of oxidative stress 
 
Genetic markers 
a. Early growth response (EGR)-1 gene 
b. P450 aromatase 
c. Placental protein 14 (PP14) 
 
Tissue markers 
a. Aromatase P 450 
b. Cytokeratins 
c. Hormone receptors 
* Adapted from Bedaiwy87 
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Figure 11.7. Revised Classification of endometriosis from ASRM 199689 
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Women with symptoms 
(dysmenorrhea, pelvic pain, 
infertility, dyspareunia) 
Searching for solution 
Information 
www.endometriose.de
Take home message 
Analyze the Information 
Reliable info: 
Roman, Novell 
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Internet 
Medical staff 
Questions and Answers 
(discussion)
Searching for Help 
Referral to Surgeon, 
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Religion, Psychological 
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Diagnostic 
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Informed concent 
Therapy 
Operation, Medical, 
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Healed Progress/Recurrence 
Impact on  
Quality of Life Supportive Therapy: 
Counseling 
Self-help group 
Endometriosis association 
Medical help Non-Medical help 
Fatigue, stress, hopelessness, 
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work, decreased productivity, 
social impact 
Figure 11.8. Illustration how a woman with 
endometriosis becomes frustrated 
Rumors, traditions 
Friends 
Families (parents, husband, 
partners, children, etc) 
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Table 11.5. Endo-Test, originally in German, translated by the author   
 Points  
1. Do you have painful periods? 
a. always 
b. sometimes 
c. seldom 
d. never 
 
1.1. If yes, when does the pain begin in your period? 
a. days before the bleeding 
b. during the time of bleeding 
 
1.2. If yes, when do you have the most pain? 
a. before the bleeding 
b. together with the bleeding 
 
1.3. If yes, have you had this pain since the first time you had your period? 
a. yes 
b. no 
 
2. Do you have lower abdominal pain monthly without having any menstrual period and 
you do not have any gastrointestinal problem? 
a. often 
b. sometimes 
c. never 
 
2.1. If yes, is this pain very deep and strong or only mild? 
a. very strong 
b. mild 
 
3. Do you also have pain during intercourse? 
a. yes 
b. no 
 
3.1. If yes, does it depend on the position at intercourse? 
a. yes  
b. no 
3.2.  If yes, where is the center point of this pain?  
a. deep vagina 
b. in the pelvic region 
c. at the entrance of the vagina 
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4. Do you also have bleeding with urination and bowel movement before or during 
menstruation? 
a. yes 
b. no 
 
5. Do you have infertility problems? 
a. yes 
b. no 
 
6. Are you currently taking any contraceptives? 
a. yes 
b. no 
  
7. Does the pain reduce your quality of life? 
a. extremely 
b. mildly 
c. no change 
 
8. Does the pain reduce your sexual activity? 
a. extremely 
b. mildly 
c. no change 
 
9. Does the menstrual pain limit your physical activity? 
a. extremely 
b. mildly 
c. no change 
 
10. Do you feel that your productivity is limited because of the pain? 
a. extremely 
b. mildly 
c. no change 
 
11. How many days does the period pain limit your working activity?  
a. >3 days 
b. 1-3 days 
c. 0 day 
 
12. How many days in a year have you been unable to go to work? 
a. >10 days 
b. 2-10 days 
c. 0-1 day 
  
 
  2 
 0 
 
 
 2 
 0 
 
 
 1 
 0 
 
 
 0 
 0 
 0 
 
 
 0 
 0 
 0 
 
 
 0 
 0 
 0 
 
  
 0 
 0 
 0 
 
 
 0 
 0 
 0 
 
 
 0 
 0 
 0 
Total of points =  
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Table 11.6. Delay in diagnosis of endometriosis   
Delay in diagnosis of endometriosis (years) Literature Pelvic pain Infertility Total 
Ballweg (2004)117 - - >9 
Husby et al. (2003)116 6.7 ± 6.2 - - 
Arruda et al. (2003)179 7.4 4.0 7.0 
Dmowski et al. (1997)176 6.35 3.13 - 
Hadfield et al. (1996)180 11.73 ± 9.05 (USA) 
7.96 ± 7.92 (UK) 
- - 
 
 
 
Table 11.7. List of experts of www.endometriose.de 
 
1. Prof. Dr. med. H-R Tinneberg, Giessen 
2. Dr. med. Klaus Bühler, Langenhagen 
3. Dr. med. Edgar Dewitt, Köln  
4. PD Dr. med. Dr. phil. Andreas Ebert, Berlin  
5. Prof. Dr. med. Göretzlehner, Torgau  
6. Prof. Dr. med. Joerg Keckstein, Villach  
7. Dr. med. Istvan Kocsis, Bonn  
8. Prof. Dr. med. Lilo Mettler, Kiel  
9. PD Dr. med. Michael Mueller, Bern  
10. PD Dr. med. P.-A. Regidor, Münster  
11. Prof. Dr. med. Thomas Römer, Köln  
12. Prof. Dr. med. A.E. Schindler, Essen 
13. Prof. Dr. med. Karl-Werner Schweppe, Westerstede 
14. PD Dr. med. Martin Sillem, Aschaffenburg 
 
 
 
Table 11.8. Number of visitors per month 
September 2004 4234 
August 2004 15587 
July 2004 15262 
June 2004 16113 
May 2004 16709 
April 2004 16475 
March 2004  17809 
February 2004  14858 
January 2004  23390 
December 2003  16190 
November 2003  12667 
October 2003  11422 
September 2003  10639 
August 2003 10093 
July 2003 13444 
June 2003 12872 
May 2003 13629 
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Table 11.11. Evaluation criteria in assessing endometriosis websites159 
1. Ownership and affiliations 
1. Website ownership, including affiliations, strategic alliances, and significant investors, should be 
clearly indicated on the home screen or via a directly accessible link on the home screen.  
2. Copyright ownership of specific content should be clearly indicated. 
3. Information about restrictions on access to content, required registration, and password 
protection, if applicable, should be provided and easy to find. 
4. Information about payment subscriptions, document delivery, and viewing should be provided 
and easy to find. 
5. Information about privacy should be provided and easy to find. 
6. Funding or other sponsorship for any specific content should be clearly indicated. 
7. Content should be easily distinguishable from advertising. 
 
2. Editorial content 
1. Content should be reviewed for quality (including originality, accuracy, and reliability) by either 
peer review or editorial boards. 
2. The language complexity of the content should be appropriate for the site’s audience. 
3. A description of the editorial process and method of content review should be posted on the site. 
4. All staff members and other individuals (i.e., editorial board) responsible for content quality 
should be posted on site. 
5. The dates on which content is posted, revised, and up-dated should be clearly indicated. 
6. Sources for specific content should be clearly identified (i.e., author byline or names of 
individual, organization, department, institution, agency, or commercial provider/producer). 
7. Affiliations and relevant financial disclosures for authors and content producers should be clearly 
indicated.  
8. Reference material used to develop content should be cited in a manner appropriate for the site’s 
audience. 
 
3. Navigation 
1. The website should provide information about the platform(s) and browser (that permit optimal 
viewing in a location that is easy to find).  
2. The intrasite content links should be functional. 
3. The external links should be functional. 
4. The website allows viewers to return to previously browsed websites. 
5. The website does not redirect viewer to unintended websites. 
6. Information on portable document format (PDF) files and software download instruction should 
be provided and easy to find. 
7. The website features include a site map.  
8. The website features include a “frequently asked questions” (FAQ) page. 
9. The website features include a feedback mechanism. 
10. The website features include customer service information.  
11. Each distinct site should provide a search engine with instructions specifying how to use the 
search function. 
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Table 11.12. Evaluation criteria in assessing endometriosis websites   
Criteria Fulfilled Percentage (%) 
Ownership and affiliations   
1. Website ownership, including affiliations, strategic alliances, and 
significant investors, should be clearly indicated on the home 
screen or via a directly accessible link on the home screen.  
16 80 
2. Copyright ownership of specific content should be clearly 
indicated. 
11 55 
3. Information about restrictions on access to content, required 
registration, and password protection, if applicable, should be 
provided and easy to find. 
9 45 
4. Information about payment subscriptions, document delivery, and 
viewing should be provided and easy to find. 
9 45 
5. Information about privacy should be provided and easy to find. 11 55 
6. Funding or other sponsorship for any specific content should be 
clearly indicated. 
15 75 
7. Content should be easily distinguishable from advertising. 16 80 
   
Editorial content   
1. Content should be reviewed for quality (including originality, 
accuracy, and reliability) by either peer review or editorial boards. 
7 35 
2. The language complexity of the content should be appropriate for 
the site’s audience. 
18 90 
3. A description of the editorial process and method of content 
review should be posted on the site. 
7 35 
4. All staff members and other individuals (i.e., editorial board) 
responsible for content quality should be posted on site. 
13 65 
5. The dates on which content is posted, revised, and up-dated should 
be clearly indicated. 
3 15 
6. Sources for specific content should be clearly identified (i.e., 
author byline or names of individual, organization, department, 
institution, agency, or commercial provider/producer). 
6 30 
7. Affiliations and relevant financial disclosures for authors and 
content producers should be clearly indicated. 
10 50 
8. Reference material used to develop content should be cited in a 
manner appropriate for the site’s audience. 
4 20 
   
Navigation   
1. The website should provide information about the platform(s) and 
browser (that permit optimal viewing in a location that is easy to 
find).  
8 40 
2. The intrasite content links should be functional. 17 85 
3. The external links should be functional. 18 90 
4. The website allows viewers to return to previously browsed 
websites. 
14 70 
5. The website does not redirect viewer to unintended websites. 16 80 
6. Information on portable document format (PDF) files and software 
download instruction should be provided and easy to find. 
12 60 
7. The website features include a site map.  5 25 
8. The website features include a “frequently asked questions” (FAQ) 
page. 
8 40 
9. The website features include a feedback mechanism. 12 60 
10. The website features include customer service information. 10 50 
11. Each distinct site should provide a search engine with instructions 
specifying how to use the search function. 
12 60 
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L E B E N S L A U F 
 
 
 
Angaben zur Person 
 
 
 
Name:     Ferdhy Suryadi Suwandinata 
 
Geburtsort:   Jakarta 
  
Geburtsdatum:  2. Februar 1977 
 
Familienstand:  Ledig 
 
Nationalität:   Indonesisch 
 
Addresse:   Liebigstraße 27, D – 35390 Gießen 
 
E-mail:   ferdhys@yahoo.com 
 
 
 
Schulbildung 
 
1982 – 1988   Christliche Grundschule Samaria  
Jakarta, Indonesien 
 
1988 – 1991   Christliche Mittelschule II (SMPK II)  
Jakarta, Indonesien 
 
1991 – 1994   Christliches Gymnasium I (SMAK I)  
Jakarta, Indonesien 
    Abschluß : Hochschulreife 
 
 
Berufsausbildung 
 
1994 - 1998   Vorklinisches Studium  
Medizinische Fakultät Universität Indonesien 
Jakarta, Indonesien 
    Abschluß : Sarjana Kedokteran ( Bsc. Med.)  
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Praktisches Jahr 
 
06.1998 – 12.1998   Innere Medizin 3 Monate 
Pädiatrie 3 Monate 
Zentrales Nationales Krankenhaus Ciptomangunkusumo – 
Klinikum der Universität Indonesien, Jakarta 
    Städtisches Krankenhaus Tangerang, Jakarta 
    Lehrkrankenhaus der Universität Indonesien 
 
01.1999 – 07.1999  Dermato- und Venerologie 
    Psychiatrie 
    Klinische Pharmacologie 
    Neurologie 
    Radiologie 
    Public Health (je Abteilung 1 Monat) 
    Zentrales Nationales Krankenhaus Ciptomangunkusumo 
     
08.1999 – 10.1999  Gynäkologie und Geburtshilfe 
    Zentrales Nationales Krankenhaus Ciptomangunkusumo 
    Städtisches Krankenhaus Tangerang 
 
11.1999 – 02.2000  Rechts Medizin  
    Ohr-Hals-Nasen 
    Augenheilkunde 
    Anästhesiologie (je Abteilung 1 Monat) 
    Zentrales Nationales Krankenhaus Ciptomangunkusumo 
     
03.2000 – 05.2000  Public Health 
    Mutter- und Kinderklinik „Utan Kayu“ 
    Familie Klinik „Kiara“ 
Jakarta, Indonesien 
    
05.2000 – 08.2000  Chirurgie 
    Zentrales Nationales Krankenhaus Ciptomangunkusumo 
Städtisches Krankenhaus Tangerang 
     
08.2000   Abschluß des medizinischen Studiums : Arzt 
 
 
Studienbegleitende Tätigkeiten 
 
Zusatzqualifikationen 
 
2000      Kurs „Advance Cardiac Live Support“  
nach American Heart Association 
 
2001     Kurs „Advance Trauma Life Support“ 
nach American College of Surgeons Committee on 
Trauma 
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EDV MS Excel, Textbearbeitung (MS Word), MS Powerpoint, 
Design graphic (Adobe Illustrator), Access, Database, 
Photographie, Photobearbeitung, SPSS, Videobearbeitung, 
Webmeister 
 
Sprachkenntnisse  Indonesisch – Muttersprache 
Deutsch – fliessend 
    Englisch – sehr gut 
      
Forschung „ Die Verhalten und Kenntnisse der Mütter über 
Immunisation ihrer Kinder und die beeinflussenden 
Faktoren im Bezirk Matraman, Ost-Jakarta “ – 2000 
 
„ Die Verhalten und Kenntnisse der Frauen über 
Menopause und die beeinflussenden Faktoren im Bezirk 
Senen, Zentral-Jakarta “ – 2000 
 
 
Kurse und Fortbildungen 
 
02.2002 Fortbildung „ Onkologische Fortbildungsveranstaltung 
der Projektgruppen des Tumorzentrums   
Tumornachsorge “, Erlangen 
 
02.2002  Kurs „ Doppler- und Farbdoppler-Sonographie in der 
Gynäkologie und Geburtshilfe “, Erlangen 
 
03.2002 Fortbildung „ Neues zur Therapie der Hypertonie bei Typ 
2 Diabetes “, Erlangen 
 
03.2002 Fortbildung „ Aktuelles in der Prävention, Diagnostik und 
Therapie von zervikalen Dysplasien und des 
Zervixkarzinoms “, Erlangen 
 
04.2002 Fortbildung „ 14. Erlanger Anästhesie-Seminar “, 
Erlangen 
     
06.2002 Fortbildung „ Mammakarzinom Früherkennung versus 
Screening “, Erlangen 
 
06.2002 Fortbildung „ Fortschritte in der Diagnostik und Therapie 
kardiovaskulärer Synkopen “, Herzogenaurach 
 
07.2002 Fortbildung „ Fortgeschrittenes Karzinom der Mamma “, 
Bayreuth 
 
11.2002  Fortbildung „ Gynäkologische Onkologie 2002 Leitlinien, 
medikamentöse Strategien und Studien “, Erlangen 
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11.2002 Fortbildung „ Grenzen der Reproduktionsmedizin “, 
Giessen 
 
11.2002   Fortbildung „ Schilddrüse und Herz “, Erlangen 
 
11.2002 Fortbildung „ Update Endometriose 2002 “, Erlangen 
   
01.2003 Fortbildung „ Giessener Gynäkologische Fortbildung   
2003 “, Gießen 
 
02.2003 Fortbildung „ 36. Erlanger Fortbildungstage für 
Praktische Medizin “, Erlangen 
 
03.2003 Fortbildung „ Perinatalkongress Frankfurt 2003 “, 
Frankfurt am Main 
 
10.2003 Fortbildung „ Kontrazeption und Hormonsubtitution “, 
Mainz 
 
11.2003 Fortbildung „ Kinderwunsch bei systemischen 
Erkrankungen “, Gießen 
 
11.2003 Fortbildung „ 1. Brustkrebs-Symposium des Brustzenturm 
Mittelhessen “, Gießen 
 
12.2003 Fortbildung „ Geburtshilfliche-Pädiatrischen    
Fortbildung “, Gießen 
 
12.2003 Fortbildung „ Radio-Onkologisch-Gynäkologischen 
Fortbildung “, Gießen 
 
03.2004 Fortbildung „ Moderne Kinderwunschbehandlung in 
regionaler Kooperation an einem IVF-Zentrum “ und          
„ Moderne Kontrazeptionsmethoden “, Herborn  
 
05.2004 Fortbildung „ Der juristische Notfallkoffer “ und                 
„ Modernes Thrombosemanagement “, Mannheim 
 
06.2004 Fortbildung „ 5. Düsseldorfer Symposium 
Mammakarzinom-Behandlung – Eine multidisziplinäre 
Herausforderung “, Düsseldorf 
 
07.2004 Fortbildung „ 203. Tagung Niederrheinisch-Westfälische 
Gesellschaft für Gynäkologie und Geburtshilfe   
(NWGGG) “, Köln 
 
07.2004   Kurs „ Mammasonographie “, Köln 
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07.2004 Fortbildung „ Carcinoma in situ der Mamma / 
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